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The interaction of cell surface receptors with extracellular ligands or biomolecules can 
potentially triggers a cascade of signaling pathways leading to varied functional 
responses in both healthy and diseased cell states. Gradients of biomolecular availability 
targeting these receptors alter signaling responses among cells. Current cell-based 
microfluidic assays which mimic in-vivo biomolecular gradients are used to study the 
effect of generating extracellular concentrations rather than bound receptor-ligand 
complexes formed on the cell surface. It is often intriguing to understand how the 
function and communication of cells change, as an effect of varied spatial availability of 
the bound signaling biomolecules.  Methods which could account for the transport and 
kinetics of formation of such bound cell surface ligand-receptor gradients would 
contribute to a better understanding of the molecular signaling events. Although, 
methods that can quantify biomolecular dissociation rates and surface receptor numbers 
on live cells have a high demand in the pharmaceutical industry, they have not been 
explored much. 
This thesis addresses the above issues by presenting three novel microfluidic cell based 
assays supported by theoretical and experimental insights. Firstly, a simple microfluidic 
flow based method of generating live cell surface ‘bound’ ligand gradients is discussed. 
These gradients are established through the flow of a small packet of biomolecules or 
bolus. This platform is robust in establishing long range biomolecular gradients for cell 
signaling studies within a few minutes.  
The second assay is a microfluidic displacement method for live cell quantification of 
dissociation (off) rate. Compared to the conventional methods based on radioligand 
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binding or surface plasmon resonance, the microfluidic displacement assay is an easy 
and cheap method to determine the dissociation as well as internalization rates of ligands 
binding to the target cell surface receptors. The binding off rate of epidermal growth 
factor to its receptor on A431 cells was determined by the assay and was validated by 
comparing with values reported in the literature using conventional techniques.   
The last assay is a microfluidic receptor quantification assay using bioluminescence. The 
use of microfluidics on a lens-free optical platform with a photon sensitive detector 
makes this a fast and sensitive method of determining cell surface receptor numbers. β1 
adrenergic receptors on the surface of cardiomyocytes were quantified using this method 
and were found to be in  good agreement with the values reported in the literature.  
I believe that these simple and efficient microfluidic cell-based assays would serve as 
an invaluable tool for studies related to cell surface receptor quantification having wide 
applications in pharmaceutical as well as biological research domains. These promising 
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The human body comprises of tens of trillions of ‘cells’ which are the structural and 
functional units of all living organisms. The cell is a complex unit comprising several 
organelles and biomolecules such as proteins, nucleic acids and polysaccharides (Figure 
1.1). Cells present in healthy human adults are quite diverse and can be classified into 
411 different types based on their physiology [1]. The physiological changes leading to 
normal and diseased states in cells are one of the characteristic effects of biomolecular 
interactions between ligands and receptors.  
 
Figure 1.1 Schematic representation of the organelles present in a mammalian cell 
(Source: Pearson Education Inc. © 2004) 
 
1.1    Cells, Receptors and Ligands  
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In technical terms, ‘Receptors’ can be any biological entity such as enzymes, re-uptake 
recognition sites, DNA and proteins [2]. However, this term is usually associated with 
proteins present on the cell surface that are concerned specifically and directly with 
chemical signaling between and within cells [3]. Biomolecules such as antibodies, 
extracelullar matrix (ECM) proteins, drugs, hormones, neurotransmitters or intracellular 
messengers which bind to receptors and result in a change in the cellular activity are 
termed as ‘Ligands’. Cell surface receptors on mammalian cells can be generalized into 
a) Ion-channel linked receptors, b) G-protein coupled receptors and c) Enzyme linked 
receptors, based on the mechanism by which they transmit signal into the cell (Figure 
1.2).  The importance of cell surface receptors (CSRs), mainly the enzyme linked 
receptors and G-protein coupled receptors (GPCRs), is well known in the 
pharmaceutical industry as these are targeted by more than 60-70% of the drugs. Thus, 
understanding the behavior of the cells in terms of their molecular properties such as 
receptor-ligand interactions has been a central goal for molecular biologists, 
biotechnologists and bioengineers [4]. Hence, it is worthy to have a better understanding 










The binding of a ligand to its receptor is the initial step leading to a cascade of reactions 
that finally cause a functional effect in a cell. A simplest possible representation of the 
ligand-receptor interaction is given by a monovalent 1:1 binding event, where a ligand, 
L, binds to a single receptor binding site, R, in order to form a ligand-receptor complex 
LR as described by:  




 𝑳𝑹                                        (1.1)           
               
1.2    Ligand – Receptor Binding 
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The rate constants represented by k1 and k2 are the kinetic association and dissociation 
rates, respectively. These kinetic rate constants are dependent on the temperature of the 
surrounding environment, medium composition such as the pH and small ion 
concentration [5]. Under equilibrium conditions, the rate of association equals the rate 
of dissociation as mentioned below: 
                                              [𝑳] ∙  [𝑹] ∙ 𝒌𝟏 =  [𝑳𝑹] ∙ 𝒌𝟐                                            (1.2)          
                                       
                                   
[𝑳]∙[𝑹]
[𝑳𝑹]
  =  
𝒌𝟐
𝒌𝟏
   =  𝑲𝑫  = 
𝟏
𝑲𝐀
                               (1.3) 
 
where, KA and KD are the equilibrium association (or affinity) and dissociation constants 
while [L], [R] and [LR] are the concentration of free ligand, free receptor and ligand-
receptor complex respectively. The affinity constant measures the equilibrium property 
of binding by giving us a quantitative understanding of the strength of the ligand-
receptor interaction. In addition to these binding rates, the cell surface bound molecule 
can be taken up by the cell through a process called ‘internalization’ [6]. The receptor-
ligand complex that is internalized further undergoes processes such as recycling and 
degradation [7]. These processes are dynamic and their rates can vary based on their 
kind and expression of receptors present among cells. Measurement of these equilibrium 
and kinetic rates can be determined through ligand binding assays. 
 
Ligand binding studies are very popular among experimentalists where numerous assay 
formats have been developed to screen and quantify receptor ligands. Since the 
interaction of a ligand binding to a receptor has a crucial role in biological systems, their 
1.2.1 Ligand binding assays 
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measurement forms a significant part of modern pharmaceutical development [8]. The 
receptor-ligand binding assays lie significant in the following areas [9], 
i. Revealing the binding scheme and elucidating the binding mechanism in 
combination with protein structural information 
ii. Acting as strategic tools in the discovery of endogenous ligands and for 
screening new drugs 
iii. Determining the receptor distribution and identification of their subtypes 
In many cases kinetic binding studies are found to have a superior resolving power when 
compared to equilibrium measurements. This is because equilibrium binding does not 
reflect the speed of the reaction i.e. how fast or slow is the binding. The central task of 
kinetic analysis is the determination of kinetic association and dissociation rates i.e. k1 
and k2 respectively. This thesis mainly focuses on the kinetics of ligand binding.  
Current methods to determine ligand binding rates prefer non-radiolabelled approaches 
in order to reduce costs, health risks and environmental pollution. Fluorophore tagged 
ligands used in methods such as total internal reflection microscopy (TIRF) [10, 11] and 
fluorescence correlation spectroscopy (FCS) [12] are used widely to determine the 
kinetic binding rates of ligands to receptors. Likewise, label-free approaches such as, 
surface plasmon resonance (SPR) [13], quartz crystal microbalance (QCM) [14] and 




Figure 1.3 Schematic representation of (a) surface plasmon resonance (b) quartz crystal 
microbalance. These images are reproduced from the references [17] and [18]. 
 
 
Receptor quantification assays are an integral part of ligand binding studies since various 
drugs are screened for their affinity towards specific receptor of interest expressed on 
cells. In addition, receptor number plays a deterministic role on the cellular physiology. 
Hence receptor quantification plays an equally important role in quantitative biological 
studies. Existing techniques which quantify surface and total receptors in cells include 
western blotting and ELISA [19], saturation binding assay [20], flow cytometry [21, 22], 
quantitative immuno histo-chemistry (Q-IHC) [23],  total internal reflection 
fluorescence (TIRF) correlation spectroscopy [24, 25] and near field scanning optical 
microscopy (NSOM) [26]. 





Cell-based assays encompass many different areas in assessing the effects of chemical 
stimuli on biological cells [27].  Microfluidics is the science of controlling fluids and 
particles at the micron and submicron dimensions [28]. Fluids flowing at these 
dimensions are dominated by their viscous properties at the expense of their inertial 
forces resulting in very low Reynolds number (Re) causing the flow to be ‘laminar’. 
This specialized flow regime allows one to calculate the movement of chemical species 
inside a microdevice with more accuracy resulting in precise spatial as well as temporal 
control of chemical/biological reagents. In addition, high surface to volume ratios and 
short diffusion distances in microfluidic channels allow biomolecules to be easily 
transported to the cells. Performing cell-based assays in microfluidic formats is 
advantageous since they have low sample consumption, rapid application of well-
defined solution, generation of complex chemical gradients and reduced cost and 
analysis time [27]. 
1.3.1  Gradient generation methods  
Dynamic flow in the human body often results in distinct temporal concentration 
gradients of drug molecules preventing them from reaching equilibrium [29].Various 
methods have been developed to generate biomolecular gradients in microfluidic 
platforms that are predictable and reproducible for cell studies. These gradient 
generation methods can usually be classified as follows:  
1.3    Microfluidics for cell based assays 
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a) Substrate bound biomolecular gradients: where micro fabricated tools [Fig 1.4 
(a)] are used to selectively absorb the biomolecules on the surface on top of which 
cells are grown [30-33]. 
 b) Time evolving gradient generators: gradients evolve over space and time through 
passive diffusion. This mainly relies on the diffusion coefficient of the biomolecule 
and the dimension of the microfluidic device [34-36]. 
 c) Steady state gradient generators: achieve time invariant gradients across cells 
through parallel flows and flow resistance respectively [Figure 1.4 (b & c)]. Both are 
dependent on the diffusive effects of the biomolecule to attain a steady state gradient 
[37-41].  
 
Figure 1.4 a) Controlled size and spacing of micropatterned substrate bound 
biomolecular gradients for growth cone studies, b) Steady state gradient generation using 
parallel flow premixer c) Flow resistive cross channel gradient generators. Images are 
taken from the literature [33, 40, 41]. 
 
1.3.2  Determination of ligand binding rates 
Conventional cell based assays which determine ligand binding rates were performed on 
well plate formats. The inherent advantage of microfluidics with low analyte 
consumption, faster performance time and controlled dosing of reagents makes it an 
ideal platform to carry out ligand binding assays. Microfluidic based binding assays to 
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determine affinity and kinetic rate constants of ligands binding to isolated receptors have 
been reported in the literature [17, 42, 43]. In addition, the kinetic association and 
dissociation rates of ligands on single cells have been measured using optical tweezers 
[44] and microbeads [45] have been studied. Fluorescence serves to play a major optical 
detection method in these studies. Nevertheless, other methods like enhanced absorption 
detection, chemi/bioluminescence and label free electrochemical detection which 
includes potentiometry and conductometry have been used so far. Optical detection of 
analyte discussed in this thesis will focus on fluorescence and bioluminescence 
respectively. 
 
Figure 1.5 (a) Schematic representation of reversible sequential binding method to 
estimate the rate of dissociation of α-CnTx-Cy5. A single cell is trapped between the 
channels using an optical tweezer. (b) Microscope image of the device used in 
fluorescent microbead method where the microbeads are trapped by sieve valves inside 
a microchannel. Images are taken from the literature [45 and 46]. 
 
 
Luminescence or cold light emission is a general term given to the phenomena in which 
photons are released at lower temperatures. It is generally classified into 16 types on the 
basis of its source. Bioluminescence is a special kind of luminescence in which 
1.4    Bioluminescence – an insight 
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production of light is from a biological entity, specifically an enzyme. Several reviews 
and books have discussed in detail the chemistry, cell biology, molecular biology, gene 
expression and in-vivo imaging of bioluminescence [46-53]. The enzyme, often termed 
as Luciferase is of different types depending on the basis of its origin. The light 
producing substrate Luciferin (light bearers), also have a structural diversity. In all cases 
the photon releasing event occurs during the transition from the peroxy-luciferin 
intermediate state to the final oxy-luciferin state (Figure 1.6). 
 
Figure 1.6 Binding of luciferin to luciferase followed by a structural change in luciferase 
and luciferin leading to light emission. This results in the conversion of luciferin to oxy-
luciferin, thus generating a photon. The structural change can also be influenced by other 
cofactors such as ATP, Mg2+ in the case of firefly luciferase. 
 
Details on the chemistry, cell biology, molecular biology, gene expression and in-vivo 
imaging of bioluminescence have been discussed and reviewed in the literature [46-53]. 
The enzyme catalyzed reaction follows either flash or glow kinetic profiles of light 
production (Figure 1.7) depending on the type and structural sequence of the luciferase 
being used. Enzymes with flash kinetic profiles have higher sensitivity due to the high 
signal intensity following a rapid decay while those with glow kinetics are less sensitive 
although they stably emit light for at least an hour. Hence one has to make use of the 




Figure 1.7 Schematic representation of enzymes exhibiting flash and glow emission 
profiles in terms of relative light units (RLU). Source 
(http://www.piercenet.com/browse.cfm?fldID=5ED78F45-0A64-A63D-7E32-
1C61D6B86112) 
    
A specific kind of enzyme can have different luminescent profiles as a result of 
mutations in its structural sequence. Unlike fluorescence, light is generated as a result of 
an enzyme – substrate reaction rather than using an external light source to excite the 
fluorophore. This contributes to almost no background from the sample itself as there 
would be no photons introduced into the system under study. Current technologies use 
bioluminescence for high throughput screening. Based on the sensitivity, time and cost 
of the assay, one may to choose between flash and glow kind of profile for their study. 


















550 - 575 62   Glow ATP biosensors 
Renilla Coelenterazine 475 36   Flash Reporter gene 
assay 
Gaussia Coelenterazine 460 – 490  19  Flash High throughput 
screening, receptor 
quantification 
Aequorin Coelenterazine 460 - 470  Flash Intracellular 
calcium sensing 
Bacterial Lumazine 490 80 Glow Cell Viability, 
Gene Reporter 




Cell surface receptors such as the G-protein coupled receptors (GPCR) and enzyme 
linked receptors like tyrosine kinase receptors are today’s major targets for the 
development of 60-70% (Figure 1.8) of novel drugs[54]. Likewise, cell based assays are 
used in more than half of the high throughput screening for target validation in early 
stages of drug screening [55]. The cost of developing a new drug has recently been 
estimated to be 1 billion dollars [56]. As a result of this, every biopharmaceutical 
company is looking for ways to reduce the costs and increase the success rates [57].  
Hence platforms which assist in improving the present measurement techniques are 
always in a high demand.  
 




Figure 1.8 Biochemical classes of drug targets for receptors, reproduced from [58]. 
 
Cells are very versatile as they exhibit dynamic receptor expression on their surface at 
different time points. Researchers initially studied the interactions of ligands in isolated 
receptor rather than the entire cell itself. Thus, there was an urge to study cell surface 
receptor-ligand interactions on whole cells, as the data obtained from such studies was 
worthy when compared to the isolated receptor forms.   
Given its inherent advantages, microfluidics serves to be an ideal platform to develop 
modern cell based assays. The study of signaling gradients and their effect on cellular 
behavior is still a nascent field, open for more inventions and discoveries through 
quantitative experimentation. Current gradient generation methods focus on maintaining 
extracellular gradients in both passive and active flow. Despite the emergence of several 
microfluidic gradient generating platforms for cell signaling studies, none of them have 
a detailed consideration of the biomolecular interaction occurring at the cell surface. In 
addition, neither has there been a simple and easy approach to determine the kinetic 
dissociation rate (off rate) constant of a ligand molecule binding to surface receptors on 
live cells nor has there been a fast and robust approach to determine cell surface receptor 
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numbers on live cells. Therefore, developing efficient microfluidic approaches that 
could address these essentials would be the primary motivation behind this thesis.  
 
This dissertation contributes to the development of three important microfluidic cell 
based assays. Firstly, an easy and fast method of generating long range biomolecular 
gradients using a packet/bolus of biomolecule is proposed. The method holds a unique 
advantage over the others by allowing one to target gradients of ligands onto the cell 
surface receptors, considering the molecular rates of binding. Such an approach would 
be quite useful for microfluidic cell based assays which study cell signaling events as 
well as diseased models which face such gradients in-vivo.  The combination of a 
mathematical model to predetermine the kind of gradient generated makes it more 
useful.   
Secondly, a method of determining ligand/drug kinetic dissociation rate from the surface 
of live cells is proposed. When compared to the standard techniques that determine 
kinetic dissociation rates, this microfluidic approach allows one to quantify the ligand 
dissociation rate as well as internalization rate on live cells. Such a method is not only 
useful for basic science research but also makes it immensely useful in the billion dollar 
pharmaceutical industry where such off rates of drugs are tested on live cells every day.  
Finally, a robust method of quantifying cell surface receptor numbers using 
bioluminescence as a method of detection is proposed.  The field of bioluminescence 
has become increasingly popular as it offers 1000 fold more sensitivity than fluorescence 
assays. The use of this method for detecting biological analytes in microfluidic devices 
makes it superior in many ways. Such microfluidic devices provide miniaturized 
1.6    Scope of work 
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detection modules with a high sensitivity, specificity, signal to noise ratios, fast response 
times and multiplex functions.  
Above all, the unique capabilities of the microfluidic displacement assay as well as the 
microfluidic bioluminescent assay make them competitive to current assays in the 
market and can potentially be commercialized.    
 
The first chapter gives the reader a general understanding of the molecular interaction 
between ligands and surface receptors on cells. It introduces the currently available 
microfluidic cell based gradient generation methods and ligand binding assays. An 
overview of bioluminescence is presented thereby giving an overall background for the 
methods that would be discussed further in the thesis.      
The second chapter published in Microfluidics and Nanofluidics, discusses a novel 
gradient generating microfluidic device.  A succinct introduction about the current 
methods of generating gradients is given. This is followed by a theory section which 
discusses the formulation of a mathematical model describing the transport and binding 
of the ligand molecules onto cell surface receptors. The design of the experimental 
system is then discussed followed by the results section. This section compares how 
different gradients could be generated by altering experimental parameters such as the 
concentration, volume and flow velocity of the bolus. In addition, the experimental 
results are supported by numerical solutions, obtained by solving the mathematical 
model.  
1.7    Organization of Thesis 
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The third chapter presents a method to estimate the kinetic dissociation (off) rate of the 
bound ligands from the surface of live cells by a microfluidic displacement technique.  
A mathematical model describing microfluidic ligand displacement from cell surface 
receptors helps to estimate the kinetic dissociation as well as internalization rates. This 
is done by fitting the model to the experimental data. Following the description of the 
experimental design, the results section presents the effect of channel length, incubation 
period, flow velocity and displacing ligand concentration on the measured rates.   
The fourth chapter describes a robust on chip bioluminescence assay to quantify surface 
receptor numbers of cells under study. Luciferase conjugated ligands/antibodies are 
targeted to the specific receptors present on the cells seeded in a confined area. The light 
produced as a result of the bioluminescent reaction is directly proportional to the total 
number of receptors present on the cells. Following an introduction describing the 
current methods available to quantify receptors; the experimental design section gives a 
detailed description of the assay. The effect of luciferin concentration, sensor exposure 
time and receptor quantification using the calibration curve are described in details in 
the results section. The results obtained using this platform is validated by comparing 
the receptor numbers obtained through other standard methods. 
The fifth chapter summarizes the above mentioned methods and the future work that 







Microfluidic Bolus Induced Gradient Generator  
 
2.1   Introduction 
The role of biomolecular gradients in inducing events like development, migration and 
differentiation in cells has been recognized and is an active area of research [59-62]. 
Different levels of biomolecular availability to implement signalling over varied lengths 
in-vivo, is seen in paracrine and endocrine signalling pathways [63, 64].  Relative 
changes in these signalling pathways alter the spatial range of signal communication by 
varying the amount of triggered ligand-receptor complexes, resulting in system disorders 
[65-68].  Earlier in vitro studies were hampered by the lack of precision of the gradient 
generation methods [60, 69].  More recently, the advent of microfluidics technology has 
enabled important questions in cell biology to be addressed by imposing precisely 
controlled gradients of analytes on a cell population [70-72].  Many steady state 
(passive) and flow based methods of establishing biomolecular gradients for cell based 
studies within mirodevices, have been described and reviewed earlier [60, 69]. Although 
many of these methods form stable concentration gradients along the channel width [41, 
73-76], they not only require continuous supply of analytes but also restrict the study of 
cellular effects to relatively shorter length scales (typically < 1 mm) and smaller cell 
numbers.   
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Methods which generate biomolecular gradients over a longer length scale (few cm) 
within a microdevice have been described recently by a few research groups [77-82].  
The method followed by Goulpeau et al. [79] produce a longitudinal concentration 
gradient by using microvalves controlling transient dispersion along the flow while that 
by Du and co-workers [77] use a passive pump induced forward flow which does not 
require the use of syringe pumps. Although these methods offer some advantages, they 
either use microvalves that make fabrication difficult or use a passive pump based 
approach where the system lacks perfusion over the period of gradient generation [77, 
81].  In addition, these studies are concerned with the generation of stable extracellular 
gradients of biomolecules instead of gradients of bound molecules. 
A few methods of producing cell surface or ECM bound biomolecular gradients have 
been reported for growth cone and neuronal guidance related studies [75, 82-85]. Joanne 
et al., developed a valve based composite gradient generator to produce diffusible and 
surface bound guidance cues. Surface bound N-shaped laminin gradient was produced 
to study the changes in polarity of growth cone responses to mean concentration 
gradients of solubilized brain derived neurotrophic factors[86]. Photo-immobilization of 
peptides allowed precise control of surface bound gradients [85]. Other approaches for 
producing pre-patterned surface bound laminin gradients on glass coverslips was 
demonstrated using principles of laminar flow, diffusion and physisorption [75, 83]. 
Although these studies demonstrated methods to produce substrate bound or patterned 
gradients, they did not contribute much towards methods which studied the experimental 
and theoretical effect of generating bound live cell surface biomolecular gradients in 
both spatial and temporal domains 
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A few researchers have produced plugs of molecules within a microfluidic device [87-
90].  Bai and co-workers [88] developed a pressure pinched injection method to produce 
nanolitre volume of plugs within a microfluidic device using microvalves.  Verpoorte et 
al. [90] demonstrated the application of Bai’s method of pressure pinched injection, on 
a monolithic column in a microchannel.  However, these studies did not incorporate any 
live cells and thus did not quantify the bound molecules. In this paper we establish 
transient gradients of bound or internalized molecules using a ‘bolus’ or small packet of 
the biomolecule which is transported over a cell population. 
Here, we demonstrate for the first time, a simple method to generate live cell surface 
bound ligand gradients by injecting a bolus into a straight microchannel.  Our method of 
generating a bolus involves direct injection of a small volume of fluid (200 nL) into the 
channel with the help of a syringe pump. The Bolus Induced Gradient Generator (BIGG) 
is a novel platform which is robust and can establish short and long range ligand 
gradients on cells rapidly.  We demonstrate this method with a well-studied ligand-
receptor system, i.e. epidermal growth factor-receptor (EGF-EGFR) [25].  The EGF 
binds to EGFR on A431 epidermoid carcinoma cell line, which is well known to over 
express EGFR’s [91].  An accompanying mathematical model best describes the 
transport and binding of the. EGF to EGFR and provides essential design guidelines for 
any ligand-receptor system considering its binding characteristics. 
2.2   Theory 




The physical system depicted in Figure 2.1 comprises a straight length microfluidic 
channel with rectangular cross section.  The designated area of the microchannel 
contains the cultured cells.  A bolus containing the ligand, is injected at the start (t = 0) 
of the experiment and travels the length of the microchannel at an average velocity (Ua) 
while undergoing dispersion, diffusion and ligand depletion by binding to cell surface 
receptors. The ligand concentration in the bolus, C, changes transiently as the bolus 
travels along the length of the microchannel due to ligand binding to the cell surface 
receptors.  The governing equation is written under the following assumptions: 
a) Experiment is conducted on a low aspect ratio (H/W=0.13) microchannel, so 
that diffusion along W can be ignored (since W>>H) 
b) The ligand undergoes a longitudinal (z axis) depth wise diffusion (Df) and an 




Figure 2.1 A schematic representation (side view) of a bolus flowing inside a 
microchannel of dimensional length (Le) and height (H) is shown. A monolayer of cells 




The governing mass balance equation (considering dispersion [92, 93]) for the ligand 
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where C is made dimensionless with inlet concentration C0, x with length (Le), z with 
height (H) and time (t) with Le/Ua, λ=Le/H, Ua is average velocity and U(z) is made 
dimensionless with Ua. Ligand diffusivity is Df and taylor-aris dispersion is Dp, giving 



















Eq (2.1) is subjected to the following initial and boundary conditions:  
At the beginning of the experiment i.e. when t=0, the bolus is not introduced into the 
microchannel hence the concentration is zero, 
0  : and  all 0,    Czxt                (2.1a) 
The flux at the lower part of the channel equals the rate of concentration change of the 







  : all 0,    1,                  (2.1b) 
The flux at the upper part of the channel is zero, i.e it represents an impermeable surface, 






xtz                (2.1c) 
Since the cells are present at a region downstream from the point of bolus injection, an 
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inlet Neumann boundary condition is introduced, 
)( 0or  )0( 1
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 -  ideal bolus shape                      (2.1d) 
The flux at the channel outlet is zero since no more binding occurs after the channel 
outlet, 












Sh 0 . 
Here. K0 is the mass transfer coefficient. Eq (2.1b) represents the concentration change 
in the bolus along the z direction as a result of mass transfer due to diffusion from the 
bulk phase to the cell surface receptors. 
The total receptor concentration (CR) at any given point of time in the microchannel, is 
defined as the difference between the initial receptor concentration (CR0) and the 
concentration of the receptors that have formed a receptor-ligand complex (CRL) 
(CR) = (CR0 - CRL)                                                                                                     (2.2) 
For the case of monovalent ligand receptor system as represented by equation (1.1), the 
rate of formation of receptor-ligand complex is as follows:  
dCRL
dt
= k1(CR0 - CRL)(CLW) - k2 (CRL)                (2.3a) 
Where (CLW) is the free ligand concentration, 







201                  (2.3b) 
The rate of change of free ligands in the bolus may be described by an additional 
equation for free ligand (CLW) based on the mass transfer model: 




                                                 
(2.4) 
where:  
















a   
CLW represents the solution phase free ligand concentration in an infinitesimally thin 
layer on the cell surface.  CRL is the bound ligand concentration which is converted to a 
superficial (volume basis) concentration.  Concentrations are made dimensionless with 
respect to the inlet concentration C0.  S is cell occupied surface area, V= SH, the 
association (kf) and dissociation (kr) kinetic rate constants, CR0 is the dimensionless 
superficial total receptor concentration. Eq (2.3b) and (2.4) are coupled to Eq (2.1) via 
Eq (2.1b) since C in Eq (2.1b) and Eq (2.4) is identical.  The length of the bolus at the 
inlet is expressed as a function of time. The time is made dimensionless with total 
channel length L, hence tbL is the dimensional length of the bolus at the inlet. 
2.2.2   Numerical Solution 
Eq (1) coupled to Eq (2.3b & 2.4) were solved in COMSOL multiphysics v3.5a using 
the convection diffusion module by direct PARDISO solver. The equations 2.3b and 2.4 
were solved simultaneously with the governing equation in order to generate the time 
dependent solution. Extremely fine mesh of the entire domain containing 10,000 
24 
 
elements was used to avoid numerical instabilities arising at the inlet (x=0). The 
numerical results were verified by comparison with analytical or numerical results for 
the special cases of, (1) no binding and no dispersion [94], and (2) no binding [95].  All 
simulations were carried out on a Laptop PC with a 2.53 GHz Intel Pentium CPU and 
4GB of RAM.  
2.3   Materials and Methods 
Most of the materials were purchased from Sigma Aldrich Singapore, unless otherwise 
stated. 
2.3.1   Microfluidic Device Fabrication 
The BIGG was fabricated using polydimethylsiloxane, PDMS (Sylgard 184, Dow 
Corning, USA) following conventional rapid prototyping and soft lithography 
techniques [73]. Briefly, an 8 inch photomask containing an array of 65 mm (Le) x 0.75 
mm (W) x 0.1 mm (H) channels was printed on a plastic sheet using commercial photo 
plotting direct write laser imagers at 50,000 dpi resolution. A silicon master with positive 
relief features was fabricated using a negative photoresist (SU-8 2035, MicroChem Co, 
USA) following standard photolithographic techniques. 
Prior to the soft lithography step and in order to prevent undesired bonding of PDMS to 
the master, the silicon master was silanized with Trichloro(1H,1H,2H,2H-
perfluorooctyl)silane in a desiccator for 15 minutes at room temperature. A mixture of 
PDMS-prepolymer and curing agent (10:1 ratio) was poured over the master, degassed 
to remove bubbles and then cured overnight at 65°C. The cured PDMS molds were 
peeled away from the master and cut to the size of standard glass slides (25 mm x 75 
mm). Channel inlets and outlets (Fig 1(b)) were punched using 1.5mm diameter Harris 
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Uni-CoreTM puncher (Ted Pella Inc, USA). Following the inlets and outlets, another hole 
was punched a few millimetres away from the main inlet, right in the middle of the 
channel using a 0.5 mm diameter Harris Uni-CoreTM puncher, in order to facilitate the 
injection of bolus. The PDMS mold was then cleaned and rinsed with Isopropyl alcohol, 
de-ionized water and blow dried to remove traces of solvents. Succeeding the cleaning 
steps, the PDMS mold was bonded permanently to a 25 mm x 75 mm, glass coverslip 
(Electron Microscopy Sciences, USA) by subjecting both of them to oxygen plasma for 
30 seconds at 200W radio frequency generator power and 450 mTorr oxygen pressure 
(March Instrument Incorporated, USA). An irreversible seal between the surface of the 
PDMS containing the microchannel and the glass cover slip was formed by sandwiching 
both the surfaces together, soon after the plasma treatment and further incubating them 
for 4 hours at 65°C. 
2.3.2   Cell Culture 
A431 cells from American Type Culture Collection (Manassas, USA) were cultured in 
DMEM  supplemented with 4.5 g/L glucose, 4 mM L-glutamine, phenol red (Hyclone, 
USA), 1 mM Sodium Pyruvate, 10% FBS (Hyclone, USA), 50000 IU/L penicillin and 
50 mg/L streptomycin. Cells were grown at 37°C in a humidified incubator maintained 
at 5% CO2 in standard T-25, tissue culture flasks.  
Once the cells were 95% confluent, they were trypsinized with  2X 0.5% Trypsin-EDTA  
(Caisson Labs, USA), centrifuged and re-suspended in DMEM complete medium to a 
count of 4.3 million cells/mL. Prior to cell seeding inside the BIGG platform, the 
microdevice was subjected to oxygen plasma treatment for 15 minutes (Harrick Plasma 
Cleaner, USA) to render the surface of the channels more hydrophilic, thus creating a 
suitable environment for the cells to attach and proliferate [96]. Inlet 5 was temporarily 
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sealed with a transparent scotch tape following which the channel was perfused with the 
cell culture medium through inlet 3, without any bubble formation within the channels. 
Once the holes 1, 2 and 4 were completely filled with medium, holes 1 and 2 were 
blocked using stoppers. A volume of 100L cell suspension at the aforementioned cell 
density was perfused from inlet 3 and allowed to pass through outlet 4 with micropipettes 
placed at both the ends acting as a source and a sink. The BIGG microdevice was then 
incubated at 37°C inside a 5% CO2 incubator and was left undisturbed for a period of 12 
hours to allow the cells to attach at the bottom of the channel. After the 12 hour 
incubation period, the cells were constantly perfused with cell culture media and were 
allowed to grow inside the channel to become >95% confluent inside the 50 mm x 0.75 
mm seeding area.  
2.3.3   Bolus Generation 
The microdevice was placed on the microscope stage (Nikon TE2000U fluorescence 
microscope) that was preset to 37°C with the help of a stage heater. FEP tubings (1/32 
id, Cole-Parmer, USA) connecting the microdevice was plasma treated to render their 
inner walls clean in order to avoid air bubbles while priming them with media without 
phenol red. Inlet 1 and outlet 2 were connected to two syringe pumps (KD Scientific and 
Cole-Parmer, USA), which were maintained at the same injection and withdrawal rate 
respectively while inlet 3 and outlet 4 were blocked with stoppers. The bolus injection 
system included a 250 L Hamilton syringe with a long stainless steel cannula placed 
on another syringe pump (New Era Pump Systems Inc., USA). Boluses of desired 
volumes were injected into the channel through inlet 5 after priming the cannula 
completely and inserting it into the inlet by removing the scotch tape. Pumps controlling 
the flow of cell media (without phenol red) inside the main channel were stopped 
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temporarily at the time of bolus injection and were resumed once the bolus was 
completely injected into the microchannel (see Figures 2.2 (a) and (b)). 
 
Figure 2.2 Fluorescence photomicrograph of a 200 nL bolus containing 0.1 mM 
rhodamine dye, traveling through the BIGG microchannel.  The bolus clearly forms a 
double parabola, where (a) depicts the frontal region and (b) shows the tail of the bolus. 
 
2.3.4   Optical Detection 
Fluorescence measurements were done with a 10X 0.3NA (CFI Plan Fluor, Nikon) 
objective. Images of cells stained with respective fluorescent ligands were captured with 
DXM1200C (Nikon) CCD camera [see Figure (2.3)] . Excitation and emission of 
Epidermal Growth Factor fluorescent tetramethyl rhodamine conjugate, EGF-TMR 
(Invitrogen, Life Technologies, Singapore) was carried out with a filter cube containing 
510-560 nm BP (Ex), 575 nm DM and 590 nm (Em) LP filters. Fluorescence intensities 
over the channel length were measured using a photon counting head (Hamamatsu, 
Japan). Mercury lamp intensity fluctuations were minimal (≈2.78%) over the period of 
intensity measurement. Photobleaching effects were negligible (≈0.7% change in 45s) 
during measurements as standard protocols from previous studies in our laboratory were 
followed appropriately.  Background intensities were first measured at selected points 
over the channel length followed by bolus injection. Fluorescence intensities at the same 
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points were measured immediately after the bolus passed through the channel. Non-
specific binding of EGF-TMR to the microchannel was negligible since the intensity 
dropped back to a baseline in the cell free area after the bolus transit. Bright-field as well 
as fluorescent images of cells were processed using ImageJ software.  Statistical analysis 
of all experimental data was carried out with the two sample student t-test, assuming 
equal variances (unpaired) with significance at p < 0.05. 
 
Figure 2.3 (a) Bright field image of a monolayer of A431 cells inside the BIGG 
microdevice, taken at 4x magnification. (b) Fluorescent image of A431 cells within the 
BIGG microchannel labeled with 50 nM EGF-TMR taken at 10x magnification. 
 
2.4   Results and Discussion 
This study is conducted in a single rectilinear microchannel with a rectangular cross 
section (see Fig 2.4) comprising 1) a short initial section, devoid of cells, where the bolus 
is injected and flow profile established, and 2) a longer section with surface attached 
cells, where the ligand binding and subsequent imaging occurs.  The mathematical 
model describes the section containing cells by quantifying the bound ligand 
(experimentally quantified by fluorescence imaging).  All numerical results are based 
on the parameter values given in Table 2.1.  Experimental results are presented for the 
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convection dominated high Peclet number regime (150 < Pef < 550), illustrating, inter 
alia, the effect of the most easily varied bolus properties, such as volume and 
concentration of ligand. 
 
Figure 2.4 A schematic representation of the optical and fluidic pathways for the Bolus 
Induced Gradient Generator. Dimensions mentioned in the figure are in mm. 
 
Table 2.1 A list of parameter values applied in the numerical calculations presented in 









Parameter Numerical Value 
Df (EGF)[97] 12.9x10
-7 cm2/s 
Dp Eqn given in [98] 
Total number of receptors/cell [99] 1.8x106 
Total number of cells in confluent monolayer 88650 
Kinetic association rate constant (kf)[99] 1.2 ± 5.6 x 10
7 M-1s-
1 
Kinetic dissociation rate constant (kr)[99] 1.6 ± 0.2 x 10
-3 s-1 
Cell covered length (Le) 50 mm 
Cell covered width (W) 0.75 mm 
Height (H) 0.1 mm 






The ideal starting shape of the bolus is a cuboidal plug.  However, the shape observed 
to form experimentally is similar to a double parabola (see Figs 2.2 (a) and (b)).  This 
parabolic shape is seen across the microchannel width, while the shape along the height 
is unknown as it is difficult to image.  For the purpose of our 2D model, we compared 
the ideal bolus shape with that of the double parabola.  A 3D model would not increase 
the numerical accuracy since the exact shape along the height is unknown.  Figure 3 
shows that the slope of the normalized bound ligand versus longitudinal distance curve 
(Pef = 172) is identical for the parabolic and plug bolus (except for the entrance region 
x < 0.05, not shown in Fig 2.5, where the slopes differ) shapes.  However, the absolute 
value of bound ligand is higher for the plug bolus shape due to the shorter transport 
distance to the cell surface. For the remaining figures, we utilize the ideal plug shape in 
our numerical calculations since there wasn’t much difference between the slopes in the 
region of study. 
 
2.4.1 Effect of bolus shape 
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Figure 2.5 The effect of bolus shape on the gradient formed.  Numerical results for the 
normalized bound ligand concentration is plotted against the dimensionless length for a 
200nL bolus volume, C0 = 50 nM and Ua = 0.0222 cm/s. Dotted line (black) represents 
a double parabola while the long dash (red) represents the ideal square shaped bolus. 
 
 
Experimental data presented in Fig 2.6, shows the difference in normalized bound ligand 
gradient between cell populations when all other parameters are fixed including a Pef of 
172.  The differences are most pronounced at x < 0.4 and much reduced further 
downstream.  The numerical result given in Figure 2.6, predicts a similar gradient to that 
observed experimentally.  Within the constraints of the approximate parameter values 
given in Table 2.1, there is a good qualitative agreement between model and experiment. 
 
Figure 2.6 Bound ligand gradient varying with cell population.  Three cell populations 
(red triangle, green circle and black circle) subjected to a 50 nM, 200 nL EGF-TMR 
bolus, Ua = 0.0222 cm/s. Data is represented as normalized intensity mean plotted 
against normalized length with a standard deviation estimated from six consecutive 
intensity measurements.   Solid line represents the model prediction. 





The flowrate or Peclet number (Pef) is an important operating parameter that may be 
used to modulate the gradient of the bound ligand curve. Although, a change in flowrate 
has multiple effects on the transport of nutrient molecules and shear stress exerted on 
cells, the transient nature of the bolus transport should allow this gradient modulation to 
be carried out without an adverse effect on the cells.  Experimental data in figure 2.7 
shows a statistically significant difference in the bound ligand gradient as  
 
Figure 2.7 Effect of Peclet number or flow rate on the gradient formed.  The data points 
represent a 200nL bolus containing 50 nM EGF-TMR conjugate perfused at Ua = 0.0222 
cm/s (red triangle - experiment, dashed line – model) and Ua = 0.0666 cm/s (filled circle- 
experiment, solid line – model). Experimental data is represented as normalized intensity 
mean for six consecutive intensity measurements plotted against normalized length. 
 
2.4.3 Effect of Peclet number (or flowrate) 
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Peclet number changes from 172 (Ua = 0.022 cm/s) to 516 (Ua = 0.066 cm/s). This is 
well supported by the numerical results, with a good agreement between model and 
experiment in figure 2.7. Nevertheless, the absolute amount of bound ligand is higher 
for lower Peclet number due to the fact that the residence time increases as flow velocity 
reduces, allowing more ligands to bind to unoccupied receptors.  
 
The concentration of ligand in the injected bolus is another adjustable experimental 
parameter.  It is important to understand how this parameter influences the gradient 
formed.  The numerical result shown in figure 2.8 is interesting as it suggests that the 
gradient remains unchanged over a range of concentrations, i.e. below the receptor 
saturation limit (see discussion on bolus volume for mole numbers).  However, the 
absolute amount of bound ligand increases with increasing concentration as expected.  
Experimental data in figure 2.8 shows statistically insignificant difference in gradient 
between the 150 and 300 nM boluses.  However, the gradient observed for 50 nM is 
statistically significant when compared to 150 or 300 nM. Although the normalized 
numerical data shows similarity between 50 nM and 150 nM concentrations, they differ 
in the absolute values of bound ligands at the initial part of the channel.   




Figure 2.8 Effect of ligand concentration on the gradient formed. The data points 
represent a 200nL bolus travelling at Ua = 0.0222 cm/s containing EGF-TMR conjugates 
of C0 = 50 nM (black circle - experiment, dotted red line – model), C0 = 150 nM (red 
diamond- experiment, black solid line – model) and C0 = 300 nM (green triangle- 
experiment, blue dashed line – model).  Experimental data is represented as normalized 




The volume of bolus injected was fixed at 200 nL for Figs 4 to 6 as it gave rise to an 
appropriate bolus length (see Fig 2.9) of about 15% of the cell covered microchannel 
length.  Typical values of the bolus length are expected to range from 2 to 20% of the 
total cell covered length.  Longer length boluses may also be suitable for certain 
experimental conditions and Fig 2.10 highlights the effect of changing bolus volume.  
The numerical result shows that an increase in bolus volume from 200 nL to 600 nL 
(length increases from 15 to 45% of total length) at a fixed ligand concentration of 50 
nM will not change the bound ligand gradient significantly although the absolute value 
2.4.5 Effect of bolus volume 
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of bound ligand will be higher for the larger volume bolus.  Note that the total moles of 
ligand are different in the two bolus volumes, changing from 14 femtomoles to 42 
femtomoles (total moles of receptor, as per Table 2.1 data is about 100 femtomoles).  
The corresponding experimental data is in close agreement with this model prediction.  
 
Figure 2.9 A normalized intensity vs. time (dimensionless) profile showing 3 
repeats(black circle, green square, red triangle) of a 200 nL bolus containing 50 nM 
EGF-TMR conjugate travelling with a velocity of 0.0222 cm/s. The intensity is 
normalized with the maximum intensity while the time is normalized with the residence 
time (L/Ua) of the bolus within the channel. The bolus width is determined at 20% of 




Figure 2.10 Effect of bolus volume on the bound ligand gradient.  The data points 
represent a bolus containing 50 nM EGF-TMR conjugate travelling at Ua = 0.0222 cm/s 
with volumes of 200 nL (black circle- experiment, black solid line – model) and 600 nL 
(red triangle - experiment, red dotted line – model). Experimental data is represented as 
normalized intensity mean for six consecutive intensity measurements plotted against 
normalized length. 
 
It is worthwhile to consider the observed quantitative difference between the model 
prediction and experimental data in Figs 2.5 to 2.10.  It is observed that the value of the 
mass transfer coefficient for any given ligand plays an important role in acquiring a 
quantitative fit. The results reported in this work have been obtained by using a K0 value 
as reported in table1.  Model and Omann [100] suggest that the value of the mass transfer 
coefficient for any ligand binding system lies in the range of the product of the 
association rate constant and the surface receptor density per cell (konR0). By considering 
this, for the EGFR expression on A431 cells, the value of K0 would then likely be in the 
range of 8.874x10-3 cm/s, further giving a better prediction of the experimental data. It 
may be noted that an increase in K0 will shift the normalized bound ligand curve to the 
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left and a decrease in K0 will shift the curve to the right with a poor fit to the experimental 
data. Besides this, one may also try to estimate the value of the mass transfer coefficient 
for a given ligand-receptor cell system from the model described in this work. This could 
be done from a given set of experimental runs with fixed channel dimensions and 
varying parameters such as the Peclet number, bolus concentration and bolus volume. 
This would eventually help in achieving a quantitative understanding of the gradients 
formed for different parameter values.  
A number of important questions may be posed about the bound ligand gradient 
generated by application of a bolus as described here.  One question involves the total 
moles of ligand, i.e. what is the outcome of different ligand concentrations and bolus 
volumes, such that the total initial moles of ligand injected remains fixed.  This is 
answered by statistical comparison of experimental data given in Figs 2.8 and 2.10.  
Comparing the bolus of volume 200 nL and C0 of 150 nM with the bolus of volume 600 
nL and C0 of 50 nM (Pef = 172), a statistically significant difference (about 90% of the 
points) of bound ligand gradient is observed.  Another question that addresses the 
specific nature of the cellular response to the bound ligand is whether one can 
independently modulate the absolute value of the bound ligand and its gradient.  Clearly, 
the results presented in Fig 2.8 suggest that this is possible and thereby allows additional 
insight to be gained.  
Furthermore, for a ligand-receptor system with known binding rates, one may pre-
determine the kind of gradients formed by varying the flow parameters. Surface plots 
obtained from numerical simulations, representing the change in the ligand 
concentration during the bolus transit in the microchannel for varying parameters is 
described in figure 2.9. As the flow rate or Peclet number increases from 172 (Ua = 0.022 
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cm/s) to 516 (Ua = 0.066 cm/s), more free ligands are present in the bolus due to shorter 
binding/interaction time of the ligands to the cell surface receptors present along the 
lower boundary (x axis) of the plot. An increase in the concentration from 50 nM to 300 
nM allows more ligands to be bound to the receptors, although there isn’t any visual 
difference in the C seen in the case of higher concentrations when the bolus passes nearly 
half and three quarter of the channel length. This is due to the higher receptor density 
system leading to increased binding of ligands in the initial part of the channel as in the 
case of EGFR over expressed in A431 cells.   
 
Figure 2.11 Surface plot representing the change in the bolus concentration (C) during 
its transit along the microchannel for varying flow parameters.  
 
The BIGG platform also allows generation of multiple gradients by injecting different 
biomolecules one at a time into a single inlet at the initial part of the channel or by 
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injecting two different biomolecules from two separate inlets present on either sides of 
the channel as subjective to the channel design [see Figure 2.12]. The former method 
would help to generate multiple unidirectional gradients while the latter method would 
help to generate bi-directional gradients. One might also be able to achieve multiple 
gradients simultaneously by injecting a bolus containing a mixture of biomolecules. 
Based on the apparent binding rates of these biomolecules and also parameters such as 
concentration, flow velocity and volume of the bolus, the user may estimate the profiles 
of the multiple gradients to assist in experiment design. 
 
Figure 2.12 Schematic representation of generating multiple ligand gradients using the 
BIGG principle. (a) Unidirectional perfusion of a bolus containing mixture of ligands 
/biomolecules. (b) Bi directional perfusion of bolus containing different biomolecules, 






2.5   Summary 
Current steady state and flow based methods of generating ligand gradients either require 
a continuous supply of ligands to establish gradients in shorter length scales or require 
the use of microvalves or other passive flow methods which generate gradients of longer 
length scales. The passive flow methods lack perfusion while establishing long range 
gradients which might impede the nutritional uptake of the cells during this period. In 
addition, the current approaches only study the extracellular gradients that is achieved 
but do not focus on the bound ligand gradients which play an important role in cell 
signalling studies.  
We overcome these issues by a simple and effective method of generating bound 
biomolecular gradients. A microchannel system that integrates a bolus generator and 
surface adhered cell culture domains has been described in this chapter. This simple 
microsystem is suitable for generating longer range gradients involving larger cell 
populations as compared to existing microfluidic systems. Owing to pressure driven 
microfluidic flow of small packets of biomolecules or bolus, a gradient of cell surface 
bound ligands is established along the length of the microchannel.  Experimental data 
for the epidermal growth factor (EGF) binding to its receptor on A431 cells is presented.  
We highlight the effect of changing Peclet number (or flowrate), bolus shape, bolus 
volume and ligand concentration on the gradient formed longitudinally in the 
microchannel.  A mathematical model describing the transient convection, diffusion, 
dispersion and binding of ligands to cell surface receptors is developed.  The current 
model provides essential design guidelines for our system with good agreement with 
experimental data. Further improvement of the current model by studying the effects on 
ligand binding due to the transverse ‘y’ direction of the bolus would bolster the use 
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practical use of this model in such gradient generation assays.  The results suggest ways 
to modulate the amount of bound ligand and the gradient independently. Moreover, this 
platform allows one to study effects in cell-cell communication by creating stimulated 
receptor gradients of varying length scale among cells inside a microchannel. This would 
be very useful for biological research where one could control/trigger a monolayer of 
















Microfluidic Displacement Assay 
 
 
Signal communication and response at the cellular level is often triggered by cell surface 
receptor - ligand interactions. These cellular processes do not only depend on the 
equilibrium strength of the triggering biomolecules, but also on the average lifetimes or 
kinetic dissociation rates of these interactions [101, 102]. The kinetics of ligand binding 
is of prime importance since it influences the distribution and activity of a given 
biomolecular ligand [103-105]. For instance, drugs that interact with G-protein coupled 
receptor’s make up more than half of all the available therapeutics present today [54, 
106, 107]. Current assay technologies that are able to estimate kinetic rates are either 
cell based or use isolated receptor forms. Measuring the kinetic rates of ligands binding 
to isolated receptors differs from the natural state of binding where the surface receptor 
is integrated with the cell membrane. Cell based assays have been developed for 
expensive detection methods like TIRM-FCS, AFM, and SPR [108-110].  The lower 
cost well plate assay systems for live cell based studies do not truly reflect an in vivo 
interaction between a cell surface receptor and a soluble ligand [111]. All these methods 
suffer from serious limitations that impact the measured kinetic rates. An important 
source of error is mass transfer artifacts that include rebinding of dissociated ligand.  




Continuous flow studies such as the SPR method [112] and flow displacement 
immunoassay[113] have been used extensively to measure binding rates of 
biomolecules. The SPR method is label free with a detectable range of about 200 nm 
from the sensor surface.  This means that biomolecular binding kinetics occurring on the 
surface of a cell cannot be determined directly but rather indirectly from the functional 
response of the cell.  In addition, the dissociation rate estimated by this method is 
acquired by diluting the channel with a flow buffer after the binding/labeling step, 
following which the bound ligands are allowed to dissociate naturally over time 
assuming that no rebinding occurs. This introduces significant errors due to mass 
transfer[108, 114].  The flow displacement immunoassay measures the dissociation rate 
of the labeled antigen from immobilized antibodies in the presence of excess unlabelled 
antigen under flow.  The flow introduces a convective mass transfer component that is 
more effective in controlling rebinding.  However, the literature does not have a detailed 
theoretical assessment of the mass transport to guide the design of flow displacement 
experiments.    
More recently, microfluidic devices have proved suitable for cell based studies due to 
large surface to volume ratios and fluidic properties that mimic in vivo environments 
[115, 116]. Microfluidic assays can shorten the incubation time for surface events by 
minimizing the diffusion distance in the microchannels and replenish the diffusion layer 
by a fixed concentration of molecules [117]. Some research activity has focused on 
modeling of microfluidic systems for bio-affinity assays with [118] and without cells 
[119-121].  Schreiter et al.[44] developed a reversible sequential (ReSeq) binding assay 
to determine single cell ligand association and dissociation kinetic rate constants using 
an optical tweezer and a microfluidic device. Although the sensitivity of this assay is 
quite good for low expression levels of receptors, the assay requires the use of optical 
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tweezers, suffers from photobleaching effects and could remain challenging for systems 
with dissociation rates lesser than 10-3 s. 
We adopted the flow displacement method to quantify live-cell surface ligand 
dissociation and internalization rates by applying microfluidic technology. We 
demonstrated this method on the well studied epidermal growth factor ligand – receptor 
system (EGF - EGFR). A mathematical model describing transient convection and 
diffusion of the displaced ligands from live cells in the microchannel has also been 
elucidated. The model takes into account the loss of surface bound ligands due to 
receptor internalization, thereby allowing one to determine the value of the 




The mathematical model as shown in Figure 3.1, describes a monovalent 1:1 ligand-
receptor binding event on the surface of live cells with k1 and k2 as the kinetic association 
and dissociation rates of the ligand. We model two important processes wherein bound 
ligand number reduces at the cell surface either due to dissociation of the bound ligand 
from the receptor or internalization of the ligand-receptor complex into the cytoplasm.  
Ligand loss due to internalization is represented by the internalization rate constant, k3.  
 





Figure 3.1 Mathematical model representing a monovalent cell surface ligand-receptor 
binding event. The receptor ligand complex formed is mainly affected by the 
dissociation and internalization rates in the displacement assay. 
 
A schematic representation of the displacement assay is described in Figure 3.2. Cells 
cultured in the bottom part of a straight microchannel with a rectangular cross section 
are exposed to the following steps in the displacement assay 1) Binding step: where all 
the receptors on the cell surface are bound (saturated) to the labelled ligand, 2) Wash 
step: where excess/free labelled ligand is washed out of the channel, 3) Displacement 
step: where an excessive concentration of the unlabelled ligand is perfused inside the 








Figure 3.2 Schematic representation (side view) of the ligand displacement method on 
live cells cultured inside a microchannel of dimensional length (Le) and height (H). The 
microchannel is first perfused with plain medium, followed by the labeled ligand (red) 
of interest that occupy (saturates) all the target cell surface receptors and finally perfused 
with the unlabelled analogue (blue) in order to displace the bound ligand of interest 
(labeled-red). Flow in the channel is represented by a parabolic velocity profile as seen 
in the channel inlet. The dotted parabolic profile shows the position of the unlabelled 
analogue flow front until which the labeled ligands have been displaced. 
 
A governing mass balance equation for the flow of displaced ligand in the microchannel 
is elucidated below with the following assumptions 
a) Experiment is conducted on a low aspect ratio (H/W=0.13) microchannel, so that diffusion 
along W can be ignored (since W>>H) 
b) The flow profile of the displaced ligands is approximated by a plug flow with a (uniform 
or averaged) flow velocity (u) 




d) The displaced ligand undergoes a longitudinal diffusion (Df) and an axial dispersion (Dp) 
during its transport along a long linear microchannel (equations for diffusion and 
dispersion mentioned in [92, 93])  
The dimensionless form of the equation considering convection, diffusion and 




























                                                (3.1) 
Where, L is the dimensionless concentration of the free labeled ligand, t is the 
dimensionless time, x and z is made dimensionless with length and height of the channel 
respectively. Pef and Pep are the Peclet numbers for diffusion and dispersion coeffecients 
respectively.  
The initial and boundary conditions for this system are as follows, 
The concentration of the displaced ligands in the channel is zero at the beginning of the 
experiment (i.e. prior to the perfusion of the unlabeled ligands), 
IC:                       0),,0(  zxtL                                        (3.1a) 
Since the displaced ligands will not be introduced from the inlet during displacement, 
the concentration at the entrance is zero, 





= 0                                        (3.1b) 
The concentration of the displaced ligand at the channel outlet is represented by a 
maxima function with the flux equal to zero, 
49 
 
Exit BC:          
𝜕𝐿(𝑡,𝑥=1,𝑧)
𝜕𝑥
= 0                                                                   (3.1c) 
The flux at the upper channel wall is zero as represented by an impermeable surface, 
Upper BC:       
𝜕𝐿(𝑡,𝑥,𝑧=0)
𝜕𝑧
= 0                                          (3.1d) 
The lower part of the channel where the cells are seeded constitute the labelled ligands 
forming receptor bound complexes at the cell surface. The flux of the displaced ligand 
here equals to the rate of concentration change of the solubilized ligand on the cell 
surface induced by displacement. 
 Lower BC:   
𝜕𝐿(𝑡,𝑥,𝑧=1)
𝜕𝑧
= 𝑃𝑒𝑓 ∙ 𝑃𝑎 ∙ exp [−𝑃𝑏 ∙ (𝑡 − 𝑥)] ∙ 𝑈𝑠𝑓(𝑡 − 𝑥)   (3.1e) 
Here we make use of a unit step function (Usf) to account for the time delay in 
displacement due to the moving front of displacing ligand in the incoming fluid. The 
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where, Df and Dp are the diffusion and dispersion coefficients respectively. RL0/H is the 
initial superficial concentration of the bound ligand. Le and H are the length and height 




Previously, we had derived an analytical solution for the above equations, assuming a 
special case of negligible dispersion, using Laplace transform and Green’s function 
[122]. It illustrated how the fluid velocity and receptor internalization rates could 
influence the ligand concentration at the microchannel outlet [123].  
 
A numerical solution considering transient convection, diffusion and dispersion of the 
displaced ligand was computed and validated against the analytical solution for the case 
of negligible dispersion i.e. by setting the value of dispersion to be zero. The 
aforementioned mathematical equations were solved in COMSOL v3.5a using the 
Convection-Diffusion module – Direct PARDISO linear system solver. Numerical 
instability leading to under shoots and over shoots while calculating the displaced ligand 
concentration at the microchannel outlet was addressed by considering crosswind 
diffusion method and using extremely fine mesh consisting of 10,000 elements.  
 
Most of the materials were purchased from Life Technologies (Invitrogen) Singapore, 
unless specifically mentioned. 
 
The microdevice was fabricated using polydimethylsiloxane, PDMS (Sylgard 184, Dow 
Corning, USA) following conventional rapid prototyping and soft lithography 
techniques [124]. Briefly, a plastic photomask containing an array of channel profiles 
having the dimension 65 mm (Le) x 0.75 mm (W) x 0.1 mm (H) was printed using a 
commercial photo plotting direct write laser imager at 50,000 dpi resolution. Standard 
3.2.2 Numerical solution 
3.3 Materials and Methods 
3.3.1 Microfluidic Device Fabrication
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photolithographic techniques were used to produce a silicon master with positive relief 
features using a negative photoresist (SU-8 2035, MicroChem Co, USA). 
The silicon master was silanized with Trichloro(1H,1H,2H,2H-perfluorooctyl)silane 
(Sigma Aldrich, Singapore) in a desiccator for 15 minutes at room temperature prior to 
the soft lithography steps in order to prevent undesired bonding of PDMS to the master. 
A mixture of PDMS-prepolymer and curing agent in 10:1 ratio, was poured over the 
master, degassed to remove air bubbles and cured overnight at 65°C. The cured PDMS 
molds were peeled away from the master and cut to the size of standard glass slides (25 
mm x 75 mm). Channel inlets and outlets (Fig 2(a)) were punched using 1.5mm diam. 
Harris Uni-CoreTM puncher (Ted Pella Inc, USA). An additional hole was punched a few 
millimetres away from the main inlet, in the middle of the channel using a 0.5 mm diam. 
Harris Uni-CoreTM puncher, to facilitate the perfusion of labelled and unlabelled EGF 
solutions respectively. The PDMS mold was then cleaned and rinsed with Isopropyl 
alcohol, de-ionized water and blow dried to remove traces of solvents. Succeeding the 
cleaning steps, the PDMS mold was bonded permanently to a 25 mm x 75 mm, glass 
coverslip (Electron Microscopy Sciences, USA) by subjecting both of them to oxygen 
plasma for 30 seconds at 200W radio frequency generator power and 450 mTorr oxygen 
pressure (March Instrument Incorporated, USA). The PDMS containing the 
microchannel was irreversibly sealed to the glass cover slip by sandwiching them both 
after the plasma treatment and further incubating them for 4 hours at 65°C.  
 
A431 cells expressing epidermal growth factor receptors (EGFR’s) were purchased from 
American Type Culture Collection (Manassas, USA) and cultured in DMEM  
supplemented with 4.5 g/L glucose, 4 mM L-glutamine, phenol red (Hyclone, USA), 1 
3.3.2 Cell Culture 
52 
 
mM Sodium Pyruvate, 10% FBS (Hyclone, USA), 50000 IU/L penicillin and 50 mg/L 
streptomycin. Cells were grown in standard T-25, tissue culture flasks kept inside a 
humidified incubator maintained at 37°C and 5% CO2. The media used for the 
displacement experiments conducted on the well & microchannel platform contained 
1% Bovine Serum Albumin (Sigma Aldrich, Singapore), along with the aforementioned 
supplements except phenol red. 
Once the cells were 95% confluent, they were trypsinized with 2X 0.5% Trypsin-EDTA 
(Caisson Labs, USA), centrifuged and re-suspended in DMEM complete medium. For 
the well based assay, ≈50,000 cells were seeded in each well into 8 well chambered #1- 
coverglass (Lab TekTM- NUNC, USA) while a count of 4.3 million cells/mL was used 
for the microchannel based experiments.  The PDMS microdevice was subjected to 
oxygen plasma treatment for 15 minutes (Harrick Plasma Cleaner, USA) prior to cell 
seeding in order to render the surface of the channels more hydrophilic, thus creating a 
suitable environment for the cells to attach and proliferate [96]. Inlet 5 was first 
temporarily sealed with a transparent scotch tape following which the channel was 
perfused with the complete cell culture medium through inlet 3, without any bubble 
formation within the channels. Once the holes 1, 2 & 4 were completely filled with 
medium, holes 1 & 2 were blocked using stoppers. A volume of 100L cell suspension 
at the aforementioned cell density was perfused from inlet 3 and allowed to pass through 
outlet 4 with micropipettes placed at both the ends acting as a source and a sink. The 
microdevice was then incubated at 37°C inside a 5% CO2 humidified incubator and was 
left undisturbed for a period of 7 hours to allow the cells to attach at the bottom of the 
channel. After the 7 hour incubation period, the cells were constantly perfused with cell 
culture media and were allowed to grow inside the channel to become fully confluent 




Figure 3.3 Schematic representation of the channel used for displacement assay with 
inlet and outlet ports corresponding to the actual experimental setup with cells cultured 
in the microchannel placed on top of the microscope stage heater. The picture also shows 
the detection area at the channel outlet i.e. at end of the cell cultured region. 
 
 
Well-based: A431 cells cultured on 8-well chambered coverglass were placed on top of 
a Olympus Fluoview FV-1000 confocal microscope stage preheated to 37°C with a stage 
heater. Displacement experiments were carried out on a per well basis. The cells were 
first labelled with 100nM EGF-TMR (Epidermal Growth Factor fluorescent tetramethyl 
rhodamine conjugate) for 5 minutes and were then washed twice with cell culture media 
in order to remove any traces of unbound EGF-TMR ligands. Following the wash step, 
a 500 nM unlabelled EGF solution (200 L volume) was added into the well to initiate 
the displacement of bound EGF-TMR ligands. The cells were imaged continuously on 
the confocal system in order to track changes on the cell fluorescence intensity over 20 
minutes.  
Microchannel-based: The assay was conducted on a Nikon TE2000U fluorescence 
microscope stage that was pre-set to 37°C with the help of a stage heater. FEP tubing 
3.3.3 Displacement Assay 
54 
 
(1/32 id, Cole-Parmer, USA) connecting the microdevice were plasma treated to render 
their inner walls clean in order to avoid air bubbles while priming them with cell media. 
Cell media (with 1% BSA without phenol red) was used in order to reduce non-specific 
binding (if any) within the channel. Media was perfused inside the channel through inlet 
1 with a syringe pump (KD Scientific, USA) at 1 L/min flow rate and exited through 
outlet 2, while inlet 3 & outlet 4 were blocked with stoppers. Two other syringe pumps 
(Cole Parmer, USA & New Era Pump Systems Inc., USA) containing a 250 and a 500 
L Hamilton syringe connected to a long stainless steel cannula respectively were used 
to inject the labelled and unlabelled EGF solutions into the channel through inlet 5, after 
removing the scotch tape. A431 cells cultured on the microdevice were first labelled 
with EGF-TMR, by perfusing a 100nM EGF-TMR solution for 5.5 minutes at 1 L/min 
flow rate. Succeeding the   Pumps controlling the flow of cell culture media inside the 
main channel were stopped during the binding and displacement steps. A wash step with 
perfusion of cell culture media for 4.5 minutes at 1 L/min flow rate succeeded the 
binding step in order to remove any unbound/free ligands within the microchannel. Once 
the signal dropped back to baseline, unlabelled EGF solution was perfused inside the 
channel through inlet 5 in order to facilitate the displacement of bound EGF-TMR 
ligands from the cell surface while signal at the channel outlet was monitored 
continuously using the optical setup.  
 
Well-based: A 60x 1.40NA (UPlan Apo) oil immersion objective was used to image 
the cells seeded on each well. The cells were optically sectioned to comprise of roughly 
10-12 slices per stack with 0.43 m slice height. Each stack was imaged once in every 




to measure the cell surface ligand dissociation rate, the slice pertaining to the cell surface 
was chosen and the change in intensity over the specified region of interest was 
measured using ImageJ software.  
Microchannel-based: Fluorescence measurements for the microchannel displacement 
experiments were done with a 10x 0.3NA (CFI Plan Fluor, Nikon) objective. Excitation 
and emission of Epidermal Growth Factor fluorescent tetramethyl rhodamine conjugate, 
EGF-TMR was carried out with a filter cube containing G510-560 nm BP (Ex), 575 nm 
DM and 590 nm (Em) LP filters. Fluorescence measurement of the eluting displaced 
EGF-TMR ligands at the channel outlet was measured using a photon counting head 
(Hamamatsu, Japan). Mercury lamp intensity fluctuations were minimal (≈2.78%) over 
the period of intensity measurement. Photobleaching effects were negligible since the 
displacement was under constant flow conditions.  Background intensity at the channel 
outlet was first measured prior to the displacement step followed by the injection of the 
displacing molecule i.e. the unlabelled EGF in this case. Non-specific binding of EGF-
TMR to the microchannel was negligible since the intensity dropped back to baseline 
during the wash prior to the initiation of the displacement step. Bright field as well as 
fluorescent images of cells in the microchannel was processed using ImageJ software.  
 
Displacement of ligand by elution in the microchannel is characterized by a rapidly 
rising peak followed by a decay curve.  Both peak height and steepness of the decay 
curve are dependent on Pa and Pb.  From the definitions, we can see that for a fixed 
channel length, Pa is dependent on the flow velocity and dissociation rate (k2) while Pb 
is dependent on the flow velocity, dissociation (k2) as well as the internalization rate (k3). 
The decay curve is mono-exponential for the case of one receptor sub-type.  The length 
3.4 Results and Discussion 
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of the channel is an important design parameter and can be varied (to change the surface 
area and cell number) when cells exhibit low levels of receptor expression thereby 
increasing the eluting displaced ligand concentration (Figure 3.4a).  On the other hand, 
average flow velocity is an operating parameter which may be easily varied as discussed 
below. For receptor systems, which exhibit same ligand dissociation rate but differ only 
by their internalization rate, the rate of the decay curve varies accordingly resulting in 
lesser peak height and steepness of the decay curve (Figure 3.4b). As k3 increases (when 
k2 is constant), more ligands get internalized allowing considerably lesser amount of 
ligands being displaced from the cell surface resulting in lesser peak heights at the 




Figure 3.4 Concentration vs. time profile representing the displaced ligand 
concentration at the channel outlet.  (a) Simulation results showing the effect of varying 
channel length (black – 5 mm, red – 10 mm, green – 20 mm, grey – 30 mm, blue – 40 
mm and pink – 50 mm) on the outlet ligand concentration. (b) Simulation results 
showing the effect of varying internalization rate k3 as displayed by the Pb term while 
k2, Le and u were fixed. Black circle, red triangle, green square and blue diamond 
represent k3 values of 0.03 min






The microchannel displacement experiment was carried out in a single rectilinear 
microchannel with a rectangular cross section (Figure 3.3) comprising cells seeded over 
a surface area of 37.5 mm2. The rate constants for the EGF: EGFR complex is 
determined by fitting the numerical model to the experimentally obtained data. Figure 
3.5 represents a surface plot obtained from the numerical solution. The arrows represent 
magnitude and direction of the total flux of the displaced ligands in the channel.  As the 
flow front pass through the channel, the bound labeled ligands are displaced by the 
unlabelled ligands present in the flowing liquid. The amount of labeled ligands displaced 
(Loutlet) over time is measured at the channel outlet. The model accounts for mass balance 
by considering that the total amount of displaced labelled ligands from the system to be 
the same as the amount of surface bound ligands on cells cultured in the microchannel 
area at the time of displacement. This is done by measuring the area under the curve 
from the Loutlet vs. time plot. Regardless of the loss in the available cell surface bound 
labeled ligands as a result of experimental delays (due to internalization), the model 
should still be able to better estimate the dissociation and internalization rate constants 
while following the aforementioned condition.  
Figure 3.5 Surface plot (side view) of bound ligand, L displaced by its analogue over 
time t, when Pa = 1.53 and Pb = 1.64. X axis represents dimensionless length and Z axis 
represents dimensionless height. Arrows represent the total flux of L (dimensionless) 
over time. 
3.4.1 Rate constants for the EGF:EGFR complex  
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The amount of EGF-TMR displaced from the A431 cell surface using unlabelled EGF, 
was monitored in the channel outlet (see Fig 4). The experimental area-under-the-curve 
for the Loutlet vs. time profile, ranged between 1.83e11 molecules to 1.96e11 molecules 
due to variation in cell density (Figure 3.6).  The flow velocity during displacement was 
fixed (u = 0.0222 cm/s). The peak heights in the experiments were nearly the same for 
all three data sets. The dissociation rate constant k2 on an average is 0.0108  0.0005 s-
1 while the internalization rate constant k3 did not vary and was fixed at 0.03 min
-1.  The 
internalization rate showed good agreement with the values reported in the literature 
while the dissociation rate was a bit higher than the values reported earlier (see Table 
3.1). More accurate estimate of these values can be achieved by controlling experimental 
parameters such as the flow velocity and the displacing ligand concentration as 
explained below. 
 
Figure 3.6 Displacement of EGF-TMR from the surface of A431 cells. (a) represents 
time variant images of the cells present inside the microchannel. (b) represents the EGF-
TMR outlet profile for three experimental data sets (blue solid circle, red triangle, green 
square) using a flow velocity, u= 0.0222 cm/s and displacing ligand concentration Cw= 
8 M. Model fit to the experimental results is represented by solid line, long dash and 






Change of incubation time (time lag between labeled ligand binding and start of 
displacement) or a delay in the displacement step may affect the measured dissociation 
and internalization rates if not accounted for correctly. When the incubation time is 
increased, i.e. more ligand-receptor complexes get internalized and, less labeled ligands 
are displaced from the cell surface, the result is lower peak height.  In our study, longer 
incubation times (> 45 minutes) resulted in cell detachment from the microchannel. For 
a fixed flow velocity (u = 0.0222 cm/s , Cw = 8M) and varying incubation times of 5, 
20 and 35 minutes [see Fig 5], the average k2 value was found to be 0.0102  0.0011 s-1 
while the internalization rate k3 was 0.03 min
-1.  
 
Figure 3.7 Effect of incubation time on Loutlet. Experimental and model fit data are 
represented for 5 (experiment- blue square, model- solid line), 20 (experiment- red 
square, model- long dash) and 35 (experiment- maroon square, model- medium dash) 
minutes incubation times. 
 
 




The average flow velocity (u), affects both the peak height and steepness of the decay 
curve owing to change in Pa and Pb.  Increasing the velocity, increases dispersion of the 
displaced ligands, leading to lowering of peak height and broadening of the elution 
profile (Figure 3.8a).  However, total eluting molecules do not change substantially 
(Table 3.1).  The convective mass transfer effect was observed in our experiments as 
there was an increase in the dissociation rate as the flow velocity was increased (Figure 
3.8b). A similar effect has been reported earlier in the displacement immunoassay 
method [113, 125, 126].   
For cells expressing high receptor densities, the concentration of the displacing 
molecule, Cw might be rate limiting, resulting in rebinding of the displaced labeled 
molecules [see effect of concentration section].  The experiments should be conducted 
over a range of flow velocities where the dissociation rate remains unchanged and 
thereby reduces mass transfer artifacts. 




Figure 3.8 Effect of flow velocity on Loutlet profile.  (a) Loutlet plotted over time for fixed 
k2 – 0.00678 [s-1] and k3-0.03 [min-1] while changing flow velocities 5.55e-5 m/s (black 
solid line), 1.11e-4 m/s (red dash dot), 2.22e-4 m/s (green medium dash), 4.44e-4 m/s 
(blue dash dot dot). (b) Experimental results with model fit for flow velocities 5.55e-5 
m/s (experiment- black circle, model- blue solid line), 1.11e-4 m/s (experiment- red 
triangle, model- blue long dash), 2.22e-4 m/s (experiment- green square, model- medium 






Effects of diffusion limitation while determining biomolecular binding kinetics have 
been studied for several years. The concentration of the displacing molecule (Cw) is a 
very important parameter when conducting the displacement assay. The probability of 
the displaced ligand rebinding to a receptor is increased by relative receptor locations 
and lack of availability of displacing ligand. Using a less concentrated displacing ligand 
solution might increase the possibility of rebinding of the displaced labelled molecules 
giving rise to misleading results. As seen in Figure 3.9 and 3.10, the dissociation rate 
(0.0018 s-1) calculated by fitting the intensity decay to a mono-exponential 2 parameter 
decay curve obtained from confocal measurements with a 0.5 M Cw was in good 
agreement with the dissociation rate calculated using the microchannel based method. 
Although the dissociation rate obtained by the confocal method isn’t the actual rate itself 
since it also represents the internalization of bound molecules in the rate of decay, the 
value obtained was used to get a general idea of the dissociation rate constant for the 0.5 
M concentration. Experiments (data not shown) conducted using a higher 
concentration of the Cw (>1 M) was not able to be captured by the imaging system 
since the fluorescence intensity dropped drastically, below the detection limit of the 
sensor, on the addition of the displacing ligand Figure 3.11 shows the effect of changing 
the inlet displacing ligand concentration from 0.5 M to 8 M in experiments conducted 
with the microchannel. The value of the dispersion coefficient is high due to rebinding 
of molecules further leading to the broadening of the Loutlet peak. The dispersion 
coefficient (literature value) was calculated theoretically from Brenner’s equation 
(taylor-aris result) as cited by Song Ying et. al [127] [(Df + ((2/105)*((u*H)
2)/(4*Df)))]. 
Df here is the diffusion coefficient as reported in the literature [97]. The kinetic 
3.4.4 Effect of displacing ligand concentration (Cw)  
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dissociation rate estimated for the 0.5 M solution is also underestimated because 
rebinding of displaced molecules might give rise to increasing rate of association thereby 
reducing the dissociation rate of the ligand under study. In experiments, it is desirable to 
prevent rebinding and thereby obtain a more accurate dissociation rate constant.  
Moreover, since our model assumes no rebinding, the experiment must try to achieve 
this condition in order to yield reasonable rate constant values. 
 
Figure 3.9 Confocal time lapse images of EGF-TMR displacement by unlabelled EGF 
on A431 cells. Internalization of bound EGF-TMR ligand is clearly seen in the 
calveolae. (a), (b) and (c) represent the rate of displacement at three different time 








Figure 3.10 Intensity decay due to displacement and internalization of EGF-TMR on 
the well plate. The overall intensity change from a given cell area was considered in the 
intensity measurement. The value of the apparent dissociation rate is calculated from the 
slope of the decay curve.  
 
 
Figure 3.11 Effect of displacing ligand concentration Cw. The figure represents the 
model and experimental data for a flow velocity, u= 0.0222 cm/s and displacing ligand 
concentrations Cw= 8M (experiment- blue triangle, model- red dash dot) and 0.5M 




Theoretically, one may establish a lower limit of the displacing ligand concentration. 
Considering the cell to be a hemisphere, with equally distributed spherical receptors on 
its surface, one may derive a simple equation for the minimum displacing ligand 
concentration on the cell surface Cweff 
                                                                                            (3.2) 
where R is total receptor number per cell, LR is extracellular diameter of the receptor, 
NAV is Avogadro number, D is diameter of the cell. 
For the case of A431 cells, R lies in the range of 1.8x106 – 3x106 and LR of EGFR is 3.8 
nm (calculated based on the molecular weight of the receptor), giving a minimum 
displacing ligand concentration (calculated by Eq. [8]) of 0.93 mM to 1.55 mM.  Thus 
the experimental data in Figure 3.11 is consistent with the requirement for higher 
displacing ligand concentration to prevent rebinding.  Note that rebinding may not alter 
the total eluting molecules but changes the shape of the elution curve by spreading 
(increased dispersion) it. 
An experiment may be prudently designed by employing a method for selecting the 
minimum displacing ligand concentration at the inlet.  The following method is proposed 
based on a mass transfer model given in the previous chapter.  An infinitesimally long 
bolus is considered in this case in order to represent the continuous flow of displacing 
ligands. All the equations remain the same as described before while equation 2.1d is 
rewritten to be 
)0( 1
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         (3.3) 
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In Figure 3.12, we plot the microchannel exiting cell surface concentration (which is set 
equal to Cweff) over the total receptor concentration (based on cell covered microchannel 
volume) versus a parameter ‘a’.  The parameter ‘a’ is a combination of, Sherwood 
number (Sh) incorporating a mass transfer coefficient (Sh = 3), the length to height ratio 
of the channel, and the Peclet number (Pe = uH/Df), such that a = Sh(Le/H)/Pe.  A family 
of curves are plotted for the parameter b, where b = Ka C0.  The equilibrium constant for 
binding of the displacing ligand is denoted by Ka (a known value).  The displacing ligand 
concentration at the inlet is C0.  Thus, one has to calculate the x and y coordinates of 
Figure 3.12 and identify the value of b graphically.  Subsequently, one may estimate C0 
from the known value of Ka. 
a [dimensionless]




























b= 6.98 x 10
2
 
b= 3.49 x 10
3
 
b= 1.40 x 10
4





b= 2.79 x 10
6
 
b= 3.49 x 10
6
 




Figure 3.12 Graphical method for estimating the minimum displacing ligand 




The table below consolidates the dissociation and internalization rates calculated for 
varying the aforementioned flow parameters such as the flow velocity (u), displacing 
ligand concentration (Cw), and incubation time. These values fall in good agreement with 
the broad range of values mentioned in the literature. However, a true dissociation rate 
could be estimated using this method by operating at a low flow velocity and a higher 
displacing ligand concentration, thus lowering the chances of rebinding of ligands. 
 




























8 5.55e-5 5 1.8370e11 3.569e-9 0.0067 0.03 
8 1.11e-4 5 1.7500e11 1.301e-8 0.0081 0.03 
8 2.22e-4 5 1.962e11 5.081e-8 0.0104 0.03 
8 2.22e-4 5 1.829e11 5.081e-8 0.0115 0.03 
8 2.22e-4 5 1.935e11 5.081e-8 0.0106 0.03 
8 2.22e-4 20 1.543e11 5.081e-8 0.0094 0.03 
8 2.22e-4 35 1.374e11 5.081e-8 0.0096 0.03 
0.5 2.22e-4 5 2.030e11 3.387e-7 0.0043 0.008 


















The rate of dissociation, kd of a ligand/drug binding to target cell surface receptors is of 
prime importance for designing drugs in modern pharmacology and molecular medicine. 
Conventional methods of determining ligand dissociation rates suffer from serious 
limitations such as lack of in-vivo environment and mass transfer artifacts. Gold standard 
methods like the BIACORE which use the principle of surface plasmon resonance do 
not allow direct measurements of kd from live cell samples. Other methods such as 
TIRM-FCS are very costly and cannot be afforded by all research facilities.  
Very few research groups have demonstrated methods to quantify kinetic dissociation 
rates from single cells using optical tweezers [44] and bead based assays [45] but lacked 
to contribute methods from a cell monolayer, since this is more relevant to in-vivo 
environments. 
In this chapter, an on-chip method of quantifying ligand-receptor dissociation and 
internalization rates has been described using a simple microfluidic system. This method 
offers the significant advantages of combining an in-vivo like microenvironment in a 
simple topology facilitating reduced mass transfer artifacts.  In addition, this method is 
quite adaptive, for cells expressing low receptor levels with a broad range of dissociation 
rates, owing to adjustable design and operating parameters.  Experimental data on the 
interaction between epidermal growth factor (EGF) and EGF receptors on the surface of 
A431 epidermoid carcinoma cells is demonstrated in this study which is accompanied 
by a mathematical model describing the transient unbinding and transport of the 
displaced ligand within the microchannel. In comparison with current methods for 




allowing multiple rate constant (internalization rate) estimation, greater accuracy and 
low cost.  Although we have demonstrated this method with labelled ligands, one may 
easily adapt to unlabelled ligands by linking with suitable downstream detectors. 
Furthermore, mass transport effects such as rebinding of ligands affecting the quantified 
dissociation rates have been addressed with a graphical guide to select the displacing 








Microfluidic Receptor Quantification Assay 
 
 
Cell surface receptors play an important role in signal communication and response. The 
development of a diseased state can also be due to changes in receptor density due to 
up-regulation or down-regulation and a disturbed balance in the (in)activation of the 
receptors [8]. For instance, the change in dopamine D2 receptors in Parkinson’s disease 
and myocardial β1 adrenoceptor down regulation in heart failure are good examples to 
portray the effect of receptor number on diseases [129, 130]. Thus there is a need to 
quantify the number of receptors expressed on both healthy and diseased cells.  
There are several approaches to quantify receptors expression in cells. Methods such as 
the saturation and competitive binding techniques are often used to determine receptor 
numbers in live or fixed cells [131]. The use of radiolabels in the case of saturation and 
competition binding methods is not amicable and requires one to be adept. Recent 
developments in near-field scanning optical microscopy (NSOM) techniques using 
fluorescent probes have also enabled a deterministic method of distribution and 
quantification of cell surface receptors [132, 133]. A localized evanescent wave 
produced at the tip of the NSOM probe helps to excite the receptor bound fluorescent-
ligand to get an image of a target receptor at the nanometer scale resolution. Although 
the near field imaging technique is a very good method for quantifying cell surface 
4.1    Introduction 
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receptors, it works best on fixed cells where the probe to sample distance can be 
controlled more accurately using a force-feedback loop. In addition, photobleaching of 
the fluorophores can also commonly occur on dry samples due to direct contact with air 
[134, 135]. 
Here, we establish a microfluidic based bioluminescence method of quantifying cell 
surface receptors.  Bioluminescence has been a staple in many quantitative analysis of 
cultured cells where promoter activity and cell viability are measured [136]. The 
luciferase catalyzed reaction leading to the emission of light from the substrate luciferin 
has added applications in monitoring tumor growth and response in imaging in-vivo [52, 
137]. Unlike fluorescence, bioluminescence does not require an external light source to 
excite the chemical reaction thus avoiding photobleaching effects. In addition, the 
virtually zero background allows one to detect bioluminescent signals with high 
sensitivity. This property of bioluminescence makes it a robust method for high 
throughput cell screening assays [138-140]. In order to obtain increased sensitivity with 
high light output from cells expressing low levels of receptors, we make use of one of 
the brightest luciferase in our study. Gaussia luciferase (GLuc) [136], obtained from a 
marine copepod, Gaussia princeps is very advantageous when compared to other 
bioluminescent enzymes. Firstly, it generates over 1000-fold higher bioluminescent 
signal intensity, when compared to Firefly or Renilla Luciferases [141]. Secondly, 
thermally stable GLuc has extremely high quantum yield for greater assay sensitivity 
[142]. Thirdly, it is an ATP independent enzyme. Thus artifacts caused by cellular ATP 
during signal generation have no effect on the signal generated. And finally the 
molecular weight of GLuc is around 20kDa and is commercially available in biotinylated 
as well as streptavidin bound form. Threrefore, GLuc is more amenable for biomolecular 
conjugation with proteins or antibodies. GLuc catalyzes the conversion of a luciferin 
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coelenterazine (CTZ), which is a common substrate for luficerases like Renilla, 
Oplophorus Aequorin etc [143-145]. 
Microfluidics has come to be an ideal platform for quantitative studies on cells with an 
increased surface to volume ratio thereby reducing reaction time and consumption of 
analytes [146, 147]. The combination of using bioluminescence for detecting biological 
analytes in microfluidic devices gives the opportunity to develop a lensfree optical 
platform with high sensitivity, specificity and signal to noise ratio. In addition, without 
the need for an external illumination, the size of the equipment can be reduced. Signals 
detected are directly related to the concentration of the analyte being studied. Hence, this 
approach allows real time signal detection with fast response times. Compared to well 
plate assays, our method has minimum time lag upon injection of luciferin.  
We demonstrate this method by quantifying β1 adrenergic receptors (β1 AR) on the 
surface of H9c2 cells. Receptor specific biotinylated antibodies (b*-Ab) bound to the 
cell surface are targeted by streptavidin-gaussia luciferase (s-Gluc) conjugates. Upon 
perfusing the channel with CTZ, the targeted receptor-antibody complexes light up to 
produce the bioluminescent signal (Figure 4.1). The total amount of light generated from 
a known population of cells per unit time and area is detected from the microfluidic 
device which is placed in contact with a lensfree photon sensitive CCD platform. The 
light generated from a population of cells is proportional to the number of receptors 
present in them. A immobilized enzyme calibration curve is used to estimate the number 




Figure 4.1 Schematic representation of s-Gluc (luciferase) conjugated antibodies bound 
to β1 adrenergic receptors present on the cell surface. Emission of bioluminescent signal 




The microdevice was fabricated using polydimethylsiloxane, PDMS (Sylgard 184, Dow 
Corning, USA) following conventional rapid prototyping and soft lithography 
techniques [124]. A plastic photomask containing an array of channel profiles having 
the dimension 65 mm (L) x 2 mm (W) was printed using a commercial photo plotting 
direct write laser imager. Standard photolithographic techniques were used to produce a 
silicon master with positive relief features using a negative photoresist (SU-8 2035, 
MicroChem Co, USA) to obtain features with 0.08 mm (H). 
The silicon master was silanized with Trichloro(1H,1H,2H,2H-perfluorooctyl)silane 
(Sigma Aldrich, Singapore) in a desiccator for 15 minutes at room temperature prior to 
the soft lithography steps in order to prevent undesired bonding of PDMS to the master. 
A mixture of PDMS-prepolymer and curing agent in 10:1 ratio, was poured over the 
4.2    Materials and Methods 
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master, degassed and cured for 4 hours at 65°C. The cured PDMS molds were peeled 
away from the master and cut to the size of standard glass slides (25 mm x 75 mm). 
Channel inlets and outlets were punched using 1.5mm diam. Harris Uni-CoreTM puncher 
(Ted Pella Inc, USA). An additional hole was punched a few millimetres away from the 
main inlet using a 0.5 mm diam. Harris Uni-CoreTM puncher, to facilitate the perfusion 
of the b*-Ab, s-GLuc and CTZ solutions respectively. The PDMS mold was then 
cleaned and rinsed with Isopropyl alcohol, de-ionized water and blow dried to remove 
traces of solvents. This was kept aside to bond with fibronectin patterned PDMS-glass 
coverslips.  
 
A 25 mm x 75 mm, glass coverslip (Electron Microscopy Sciences, USA) was coated 
with PDMS. Briefly, a PDMSmix consisting of 10:1 ratio of base to curing agent was 
mixed with hexane in a 1:1 ratio. Around 1.5ml of the PDMSmix : hexane mixture was 
poured uniformly over the glass coverslip and spin coated at 6000 rpm for 30 seconds. 
The PDMS coated glass coverslips were baked in 60°C for 4 hours resulting in ≈6 m 
thick PDMS coating on the glass coverslip (Appendix 4, A.4.1). The freshly baked 
PDMS-glass coverslips were then prepared to be coated with fibronectin patterns to 
facilitate cell adhesion.  
The process of patterning fibronectin onto the PDMS coated glass slides is illustrated in 
Figure 4.2(a). Stencils of representative designs were made using a laser cutter 
(Universal Laser Systems, USA) which cut an array of squares (side - 500 m) onto 
0.015in thick silicone sheets (Stockwell Elastomerics, USA). The silicone stencils were 
then washed thoroughly with 70% ethanol to remove debris from the cutting process. 
4.2.2 Fibronectin patterning on PDMS-coverslips 
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The silicone stencil was then placed on top of the glass coverslip covering most of it 
except the areas which had the squares. The coverslip with the silicone stencil was then 
subjected to oxygen plasma for 30 seconds at 200W radio frequency generator power 
and 450 mTorr oxygen pressure (March Instrument Incorporated, USA). Following the 
plasma treatment, 1 L of 50 g/mL fibronectin solution (Sigma Aldrich, Singapore) 
was placed on the exposed area and incubated at room temperature for 30 minutes. The 
exposed area was then washed thrice with DI water following which the stencils were 
removed. The patterned area was then covered with a small rectangular piece of silicone 
sheet and then exposed to plasma along with the PDMS-mold. The small rectangular 
silicone sheet was removed and the fibronectin patterned PDMS-coverslip was aligned 
and bonded to the PDMS molds in order to form microfluidic device. The microdevice 
was then incubated at 37°C for 6 hours in order to facilitate tight bonding. 
 
Figure 4.2 (a) Schematic representation showing the method of patterning fibronectin 
onto PDMS-glass coverslip. (b) Schematic representation of cell islands on fibronectin 
patterned area on a microfluidic chip. The fluidic inlets and outlets for perfusion of cell 




A431 and H9c2 cells expressing epidermal growth factor receptors (EGFR’s) and β-
adrenergic receptors respectively, were purchased from American Type Culture 
Collection (Manassas, USA) and cultured in DMEM  supplemented with 4.5 g/L 
glucose, 4 mM L-glutamine, phenol red (Hyclone, USA), 1 mM Sodium Pyruvate, 10% 
FBS (Hyclone, USA), 50000 IU/L penicillin and 50 mg/L streptomycin. Cells were 
grown in standard T-75, tissue culture flasks kept inside a humidified incubator 
maintained at 37°C and 5% CO2. The media used for the bioluminescence experiments 
conducted on the microchannel platform contained 1% Bovine Serum Albumin (Sigma 
Aldrich, Singapore), along with the aforementioned supplements except phenol red. 
Once the cells were 95% confluent for A431 cells and 70% confluent for H9c2 cells, 
they were trypsinized with 2X 0.5% Trypsin-EDTA (Caisson Labs, USA), centrifuged 
and re-suspended in DMEM complete medium at concentrations of 3 and 1million 
cells/mL for A431 and H9c2 respectively. Prior to cell seeding inside the channel, the 
device was passivated with 1% Pluronics F-127 (Sigma Aldrich, Singapore) for 30 
minutes. The channels were then flushed with cell culture media preceding cell seeding. 
50 L of cell suspension at the aforementioned concentrations were perfused inside 
different channels through the cell seeding inlets and outlets with micropipettes placed 
at both the ends acting as a source and a sink, while the other ports were blocked with 
stoppers. The microdevice was then incubated at 37°C inside a 5% CO2 humidified 
incubator and was left undisturbed for a period of 2 hours to allow the cells to attach to 
the fibronectin patterns. The unbound cells were flushed away by perfusing media 
through the main inlet. The cell seeding inlets were blocked allowing a constant 




cells were confluent in the fibronectin patterned area (Figure 4.2 (b)). After the pattern 
area was confluent to form cell islands (see Appendix 4, A.4.2), they were imaged using 
a normal bright field microscope, to estimate the total number of cells per island. The 
microfluidic device containing the cells were placed on top of the fibre optic face plate 
and made unmovable using a scotch tape. The main inlet was connected to a syringe 
pump (Kd Scientific, USA) controlling the flow of cell culture media while the receptor 
specific ligand, s-Gluc and CTZ were operated by individual syringe pumps and injected 
through the adjacent inlet. Ligand solutions used in the experiments were 100 nM 
biotinylated-EGF [b*-EGF] (Life Technologies, Singapore) for A431 cells, while a 
1:100 dilution of 0.1g/L β1 Adrenergic receptor pAb (Enzo Life Sciences, 
Switzerland) corresponding to the n-terminal region was used for the case of H9c2 cells. 
Initially, the receptors were allowed to saturate with the target ligand following which 
100 nM streptavidin conjugated Gaussia luciferase [s-Gluc] (Avidity, USA) and 100 M 
Coelenterazine [CTZ] (Avidity, USA) solutions were perfused sequentially. Flow 
velocities of 0.031cm/s for 3 minutes were used during the ligand, s-Gluc and CTZ 
injection steps. Prior to the addition of the s-Gluc and CTZ respectively, cell culture 
media was perfused at 0.042 cm/s flow velocity for 2 minutes to remove any 
unbound/free molecules added previously into the channel.  No loss or detachment of 
cells was observed during the aforementioned perfusion steps.  
 
Bioluminescence signal was detected using a deep cooled back illuminated CCD 
camera, PIXIS_XF 2048F (Princeton Instruments, USA) with a large area sensor 27.6 x 
27.6 mm2 having a 13.5 x 13.5 m pixel size (Figure 4.3). A fibre optic faceplate with a 
6 m fibre size was permanently coupled to the sensor in order to serve as an optical 
4.2.4 Optical detection 
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waveguide increasing the efficiency of signal transmission from the fluidic device to the 
sensor. Upon finally perfusing the substrate/coelenterazine solution into the channel, the 
camera recorded the bioluminescence signal from the cell islands continuously at 0.5 
frame per second. There was negligible signal generated as a result of non-specific 
binding of s-Gluc to the cell islands which was tested by perfusing s-Gluc and CTZ 
solutions respectively without the b*-EGF. The 16-bit images were processed using 
ImageJ software. The measured signal intensity was corrected for the background noise 
and displayed as relative light units in the intensity plots presented in the results and 
discussion section. 
 
An enzyme calibration curve was obtained by incubating different dilutions of the s-
Gluc on a standard 22 mm x 22 mm biotinylated glass coverslip (Microsurface inc., 
USA). This biotinylated coverslip with approximately 1014 biotin/cm2 served as a 
platform to immobilize different dilutions of s-Gluc. Briefly, a silicone gasket containing 
rectangular microwells (4 mm x 1 mm x 0.5 mm) was placed on top of the biotinylated 
coverslip to serve as a stencil. Different s-Gluc dilutions 0.07, 0.21, 0.36, 0.43, 0.57, 
0.71, 0.86 and 1x of 1 L volume were added on to the micro wells respectively and 
were incubated for half an hour to attain equilibrium. After incubation, the coverslip was 
rinsed with DI water following which the silicone stencil was removed and replaced by 
a PDMS block containing 0.3 mm wide microchannels (Figure 4.3). This was placed on 
the faceplate and signal was collected at 0.5 frame per second (or 2 s exposure 
time/frame) upon perfusing 100 M CTZ solution.   
 





Figure 4.3 Method of producing immobilized enzyme patterns to generate calibration 
curve. Silicone stencil is first placed on the glass coverslip and allowed to adhere firmly 
(a-b). Different dilutions of s-Gluc solutions are added carefully into the microwells (c). 
The stencil is removed after the incubation period (d). PDMS-microchannels 
sandwiched on top of the glass coverslip (e). This is followed by the injection of CTZ to 
produce light (f). 
 
 
We describe a fast and easy method of quantifying cell surface receptors using 
quantitative bioluminescence and microfluidics. Our method works by using a 
biotinylated antibody that binds to a specific receptor of interest. Upon saturation of 
receptor by the bound biotinylated ligand, a streptavidin conjugated gaussia luciferase 
(S-Gluc) is bound to them. Light is produced when coelenterazine reacts with the 
luciferase. The total amount of bioluminescent signal, ST (RLUm-2s-1) generated by a 
4.3    Results and Discussion 
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finite number of cells (Cn) present in a cell seeded area Csa, is proportional to the total 
number of receptors, RT.  
The number of receptors per cell, Rcell can then be determined by:  
Rcell= RT Csa/ (CnB*LR)                                                                               (4.1) 
where B*LR is the biotin/pAb labelling ratio. 
Bioluminescent signal from a cell standard with a known Rcell is first used to calculate 
the number of immobilized enzyme molecules in the calibration curve (see calibration 
curve results section). This can then be used to determine Rcell from H9c2 or any other 
cells in a similar manner. Furthermore, the effect of substrate (CTZ) concentration and 
effect of exposure time on the signal generated have been studied and optimized for this 
system.     
 
The concentration of the substrate i.e. [CTZ] plays an important role in the light emission 
kinetics of the bioluminescent reaction. ST is less when a lesser concentration of the 
substrate [CTZ] is used. This is because at lower [CTZ] concentrations not all the 
enzyme molecules react with the substrate to produce light per unit time. However, when 
one uses a higher substrate concentration, almost all the enzyme molecules react with 
equal number of substrate molecules per unit time. Hence it is essential to operate at a 
sufficient amount of substrate concentration in order to carry out a better measurement. 
Figure 4.4(a) shows the effect of substrate concentration [CTZ] on different immobilized 
s-Gluc dilutions (0.36, 0.5 and 0.71x) that were immobilized on the biotinylated glass 
coverslip. It is clear that lower [CTZ] concentrations 10 M and 30 M produce lesser 
4.3.1 Effect of substrate concentration and exposure time 
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amount of signal per unit time and area when compared to the higher concentrations 50 
M and 70 M respectively. 
 
Figure 4.4 (a) Effect of substrate concentration [CTZ] on the total amount of light 
produced by the bioluminescence reaction. Error bars represent the standard deviation 
from the average light intensity produced (RLU m-2s-1) calculated from area under the 
curve for 10, 20 and 30 second integrated times respectively. Varying apparent 
concentration of S-Gluc solutions 0.36, 0.5 and 0.71x was used in each well to form 
different immobilized Gluc densities respectively. (b) Effect of exposure time in the total 
amount of light produced by the bioluminescence reaction. Varying dilutions of S-Gluc 





Although there would be continuous perfusion of substrate molecules in a microfluidic 
flow system (as in this case), the user still has to operate at a sufficiently high substrate 
concentration so that all the enzyme molecules are actively involved in light production 
leading to better quantitative results. Thus a sufficiently high concentration 100 M of 
CTZ was used in all the experiments conducted with cells. 
The exposure time is also an important parameter for quantitative measurements with 
bioluminescence. Increasing the exposure time would improve the detection of fainter 
signals by ruling out instrumental delays caused while capturing continuous frames with 
lesser exposure times. The flash kinetic profile of Gaussia luciferase (Gluc) requires the 
user to detect signal instantaneously since the peak height as well as ST is an important 
factor while quantifying enzyme concentrations. Figure 4.4(b) describes the effect of 
different exposure times on ST from increasing amount of immobilized enzyme 
molecules. Higher immobilized enzyme densities leading to more signal would saturate 
the sensor at longer exposure times. Hence, an appropriate balance should be struck 
between the exposure time and immobilized enzyme concentration so that the sensor 
does not get saturated while maintaining a good sensitivity. An exposure time of two 
seconds was found to best suit the experiments with A431 cells (over expressing 
EGFR’s) with the given cell seeded area Csa, while an exposure time of ten seconds was 
used in the case of H9c2 cells since the signal obtained from them was faint due to lower 
β1 adrenergic receptor expression. In addition, the Cn occupied in the Csa was also less 






The stock concentration of the s-Gluc complex is difficult to determine from protein 
assays since the streptavidin moiety is also accounted during quantification. Moreover, 
in order to quantify the cell bound receptors from adherent cells, it is necessary to obtain 
a calibration curve from immobilized enzymes since this best represents the system 
under study and avoids any loss in signal caused due to scattering or dispersion which 
could take place in solution phase free enzyme form. An alternate approach of 
considering a cell standard to calculate the actual number of immobilized molecules for 
the calibration curve is suggested.  
The epidermoid carcinoma A431 cell line was found to overexpress EGFR’s (Rcell = 
1.8x106 – 3x106) on the cell surface by using different methods [99, 148-150].  This was 
considered to be an appropriate cell standard for our study since it stably over expressed 
EGFR on the cell surface, as reported in the literature by using quantitative methods 
such as radiolabelling and positron emission tomography (PET).    
Total bioluminescent signal ST (RLUm-2s-1) obtained from the A431 cells per unit area 
and time was determined by performing a flow experiment as mentioned in the methods 
section.  Cn was counted visually by capturing an image using a bright field microscope. 
The Rcell value from the literature was then used to determine the RT as mentioned in 
equation 1.   
An area normalized value of the Rcell i.e. molecules/m2 and its ST (RLUm-2s-1) was 
used to calculate the immobilized receptor density for the 1x enzyme dilution by 
correlating to its signal (RLUm-2s-1) obtained from the calibration experiments.  The 
immobilized densities from the other dilutions are interpolated by the same way as 
4.3.2 Calibration curve 
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mentioned above. The immobilized enzyme densities and their corresponding ST 
(RLUm-2s-1) have been mentioned in table 1.  
The surface plot in Figure 4.5(a) shows the peaks representing integrated signal 
intensities obtained by varying the immobilized enzyme densities while Figure 4.5(b) 
shows the corresponding intensity plot seen in 2D. The total amount of signal generated 
by each spot is normalized per unit area and time and plotted against the total amount of 
immobilized S-Gluc molecules per unit area to obtain the calibration graph. Figure 4.5(c) 
shows the calibration curve fit to a single parameter exponential growth model with an 
equation, y = e0.0016x. 
 
Figure 4.5 Calibration standards for different amount of immobilized enzyme molecules 
obtained by incubating varying enzyme concentrations. (a) & (b) Surface and intensity 
plot of integrated signal for the immobilized enzyme concentrations obtained by 
perfusing CTZ inside the microchannel. (c) calibration curve for  signal obtained from 
varying immobilized enzyme concentrations . Error bars represent the standard deviation 
from the average light intensity produced (RLU m-2s-1) calculated from area under the 






Table 4.1 Immobilized enzyme densities calculated from the standard cell intensity. 
  
ST (RLU m-2s-1) Calibration 
Average S.D Dilution 
Molecules/m2 when 
Rcell= 3x106  
Molecules/ m2 when 
Rcell = 1.8x106 
5.49E-02 1.13E-03 0.07 183.39 109.93 
2.39E-01 9.43E-03 0.21 550.17 329.79 
8.14E-01 3.20E-02 0.36 916.95 549.64 
1.14E+01 3.52E-01 0.43 1100.34 659.57 
1.48E+01 1.24E+00 0.57 1467.12 879.43 
1.60E+01 1.16E+00 0.71 1833.89 1099.29 
3.32E+01 4.24E+00 0.86 2200.67 1319.14 
5.88E+01 1.23E+01 1.00 2567.45 1539.00 
Best fit equation y = e0.0016x y = e0.0026x 
 
 
A431 cell standard:  
The signal generated by the microfluidic cell islands are used to determine the total 
amount of receptor molecules per cell. Prior to the microfluidic cell island experiments, 
the binding of the b*-EGF and S-Gluc complex to cell surface EGFR’s were first 
validated on a 8-well confocal chamber and imaged with a 60x 1.45NA objective, -70°C 
cooled EMCCD camera (Andor Technology) to capture bioluminescence signal from 
the bound EGF (ligand) molecules. Briefly, the cells were labeled with b*-EGF first 
followed by the addition of s-Gluc which bound to the b*-EGF molecules. 
Coelenterazine (CTZ) was then added to the wells and simultaneously imaged with the 
aforementioned ultrasensitive EMCCD camera. Figure 4.6(a) shows a clear 
representation of the bioluminescent signal obtained from the cell surface in relation to 
4.3.3 Receptor quantification from cell islands 
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the fluorescent signal obtained from EGF-TMR labeled A431 cells [see Figure 4.6(b)]. 
Both the images show clear cell surface expression of EGFR’s further supporting the 
fact that the binding of the b*-EGF and s-Gluc is specific to the receptor of interest. 
The cell standard cultured on fibronectin islands as mentioned in the materials section is 
then placed on the lensfree platform to quantify ST. Figure 4.6(c) represents the signal 
produced by two representative cell islands. It’s clear from Figure 4.6(c) that the 
difference in cell numbers for the island area gives rise to more signal (RLU) correlating 
with the Cn. Figure 4.6(d) exhibits integrated signal over time obtained by perfusing 
CTZ to the s-Gluc bound to the cell islands. Cells were grown on each of the square and 
alphabetic (NUS) patterns.    
 
Figure 4.6 (a) and (b) show the bioluminescence and fluorescence images of EGF-
EGFR complex on live A431 cells. (c) Bioluminescent signal emission profiles from 
square cell islands containing 315 cells and 298 cells respectively. (d) Integrated 
bioluminescence signal plot of cells cultured in square and patterned fibronectin on a 
microfluidic device.   Bioluminescent signal obtained from A431 cell surface receptors 




H9c2 cell sample: 
The back illuminated CCD camera used in our experiments increased the quantum 
efficiency to >95% allowing one to detect faint signals from the cell islands expressing 
low receptor numbers. The β1 adrenergic receptor expression on H9c2 cells was found 
to be a suitable platform to validate our method. Rabbit β1 adrenergic receptor pAb was 
first biotinylated following standard biotinylation procedure using the ChromaLink 
Biotinylation kit. UV measurements in NanoDrop instrument revealed that around 6 
biotin molecules per antibody were conjugated using this kit. This conjugation or 
labelling ratio of biotin molecules was taken into account while determining Rcell value. 
Following the biotinylation procedure the specificity of the β1 pAb was checked by 
allowing them to bind to H9c2 cells. The β1 adrenergic receptor targeted pAb on these 
cells were then labelled with streptavidin conjugated Alexa Fluor- 488 (s-AF 488). 
Confocal imaging of these live cells revealed surface binding of the pAb as shown by a 
slice represented in Figure 4.7 (a).   
 
Figure 4.7 (a) Confocal slice of H9c2 cells showing surface expression of β1 adrenergic 
receptors labelled with pAb conjugated s-AF 488 (green). Nuclei have been stained with 
DRAQ5 (red) (b) Bioluminescent signal emission profiles from square cell islands 
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containing H9c2 cells with a Cn of 75 and 63 respectively. The emission profile of A431 
cells is also shown in this plot to compare the signal intensities between the two cell 
lines grown with the same cell seeding area, Csa.  
 
Rcell value for the case of H9c2 cells were determined by fitting the total amount of 
bioluminescent signal produced per unit area and time, ST for H9c2 cells into the 
calibration curve equation. The number of β1 adrenergic receptors 
 on the surface of these cells was finally determined by further dividing this value by the 
biotin labelling ratio, B*LR (corresponding to one biotin pAb binding to six s-Gluc) as 
mentioned in table 4.2.  
Table 4.2 Values used in the bioluminescent assay for A431 and H9c2 cell line. Rcell 
calculated using this assay for H9c2 cell line is also mentioned. 
 









≈1.8 – 3 
x106 [99, 149, 150] 









The range of Rcell for the case of A431 cells provided in the literature lies between 
1.8x106 to 3x106 receptors/cell for which two calibration curves with a mono 
exponential fit were plotted respectively. The corresponding β1 adrenergic receptor 
numbers obtained from the best fit equations for H9c2 cells are 3.12x105 and 5.08x105 
as mentioned in table 4.2. Given the inherent receptor numbers expressed in the cell 
standard, the β1 adrenergic receptor numbers determined for the case of H9c2 cells are 




Receptors at the cell surface are well known to trigger functional responses in cells. 
Quantifying the receptor numbers on cells is very important to have a better 
understanding of their behaviour and functional response to external stimuli.  Primitive 
methods for receptor quantification used saturation binding of radiolabelled ligands in 
order to determine the cell surface receptor number. However, the advent of fluorescence 
based assays relieved the use of harmful radiolabelled compounds. Current fluorescent 
based methods that allow quantification of receptors from cells such as the NSOM are 
either very laborious or do not maintain the cells in their native state.  
An integrated approach was demonstrated to be adopted in this study where the high 
sensitivity of bioluminescence, high precision fluid control of microfluidics and small 
footprint of lensfree optics are blended to create a promising method of quantifying cell 
surface receptors. β1 adrenergic receptors expressed on the surface of H9c2 
cardiomyocytes were quantified using this method. A cell standard i.e. A431 cells with 
surface EGFR expression was used to relate the signal intensity to the corresponding 
number of immobilized molecules for the calibration curve. A receptor number of 3.12 
x 105 – 5.08 x 105 receptors/cell determined by this method was found to be in good 
agreement with the values mentioned in the literature.  Nevertheless, this robust 
bioluminescence method for live cell surface receptor quantification is fast and easy to 
use. Such a method will be very useful for quantitative measurements in any laboratory 
or biopharmaceutical industry. 
  
  




Conclusions and Future work 
Quantitative studies provide a fundamental understanding behind the dynamics of 
biological events. Performing cell based assays to determine the characteristics of the 
cell under study, helps in profiling them for screening new drugs and to study their 
signalling effects in response to different stimuli. Microfluidic cell based assays carry a 
huge impact on biological research being carried out today. The inherent advantages of 
conducting such assays on microfluidic devices make it an amicable, cheap and highly 
integrated platform. Three novel microfluidic cell based assays addressing the formation 
of ligand-receptor gradients, estimation of kinetic rate constants and rapid quantification 
of cell surface receptor numbers have been discussed in this thesis. 
 
A simple microchannel system, integrating a bolus generator with surface adherent cells, 
is presented.  This system is especially suited to generate transient gradients of cell 
surface receptor bound or internalized ligands.    An accompanying mathematical model 
describing the transport and binding of a biomolecule or ligand yields good agreement 
with the experimental data of averaged intensity from cell surface bound fluorescent 
ligand.  This method may be easily extended to generate multiple gradients of 
biomolecules over a cell population, for the study of cell response under well controlled 
conditions. In addition, the BIGG platform allows the user to study effects in cell-cell 
communication by creating stimulated receptor gradients of varying length scale among 
cells inside a microchannel.  
5.1    Microfluidic bolus induced gradient generator 
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 Several studies exhibit the importance of β adrenergic receptors in heart failure. One of the 
reasons that cause a heart to fail is associated with arrhythmic contractions of the heart where 
signalling of these receptors play an important role. The effect of generating surface 
gradients of cardiac β adrenergic receptors over a beating cell monolayer using the BIGG 
method, would help us create an ideal surface model of a diseased heart as seen in cardiac 
arrhythmia. Understanding variation in the gross cAMP concentration, contractility rates 
and cell viability under such levels would contribute in advancement of therapies against 
this diseased state.   
 
An on chip method of quantifying ligand-receptor dissociation and internalization rates 
has been demonstrated using a simple microfluidic system. This method offers the 
significant advantages of combining an in vivo like microenvironment in a simple 
topology facilitating reduced mass transfer artifacts.  Furthermore, this method is quite 
adaptive, for cells expressing low receptor levels with a broad range of dissociation rates, 
owing to adjustable design and operating parameters.  In comparison with current 
methods for determining dissociation rates, the microfluidic displacement method is 
competitive for allowing multiple rate constant (internalization rate) estimation, greater 
accuracy and low cost.  Although we have demonstrated this method with labelled 
ligands, one may easily adapt to unlabelled ligands by linking with suitable downstream 
detectors.  
The displacement assay has been carried out on a microscope stage. However, this can 
be further miniaturized by using compact optics with a platform to hold the microfluidic 
device inside a black box containing a lens, necessary filters and a sensitive PMT. 
Developing such a system would help in making it portable and would further bolster its 
5.2    Microfluidic displacement assay 
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use as standalone equipment that could be commercialized. In addition, the microfluidic 
device can be further re-designed to allow multiplexing thus screening and estimating 
many cells at the same time. This approach would be very useful for conducting high 
throughput screening of different drugs in varied cell systems. 
 
Cell surface receptor quantification provides deeper insights in understanding the effect 
of physiological processes occurring in cells. Current techniques of receptor 
quantification such as radiolabelling and PET are quite laborious and harbour safety 
regulations and handling issues with the use of radio-isotopes. Similarly, the use of 
fluorescent methods as in the case of NSOM increases the complexity of the assay and 
requires the cells to be fixed. Hence, cells are not assayed in their natural state. 
A fast and robust method of determining cell surface receptor number using quantitative 
bioluminescence, microfluidics and compact lens free optics has been demonstrated in 
this work. The use of bioluminescence is safe and allows the user to quantify receptor 
numbers in the native cell state without fixing it. A cell standard is initially used to 
calibrate the immobilized receptor density corresponding to the bioluminescent signal 
emitted. Around 3.12 x105 – 5.08 x 105 β1receptors / h9c2 cell quantified using our 
method was found to be in very good agreement with the values reported in the literature 
using the near field scanning technique. 
In conclusion, this method can be used in basic science research for high throughput 
screening of cell surface receptors expressed on live cells cultured in a microfluidic 
platform. Variation in receptor expression as a result of up/down regulation due to drug 
treatment and other environmental factors can also be potentially quantified. Moreover, 
5.3    Microfluidic receptor quantification assay 
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this powerful technique could also allow one to determine heterogeneity in receptor 
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Table A.1.1 A431 cell surface area measurements. A total of 101 cells were counted. 











1 134.13 23 383.79 45 475.16 67 403.97 89 384.21 
2 530.43 24 352.97 46 551.58 68 296.48 90 148.45 
3 289.64 25 724.18 47 362.30 69 431.08 91 257.55 
4 128.90 26 276.46 48 235.30 70 315.05 92 365.59 
5 438.26 27 391.48 49 529.16 71 165.25 93 390.90 
6 747.57 28 400.64 50 354.4 72 812.72 94 221.66 
7 616.77 29 328.10 51 377.92 73 643.41 95 333.38 
8 726.29 30 274.86 52 347.99 74 243.45 96 305.51 
9 679.98 31 618.88 53 528.8 75 688.46 97 385.52 
10 404.56 32 424.5 54 590.97 76 722.54 98 357.28 
11 435.68 33 335.7 55 419.81 77 1059.0 99 205.40 
12 416.43 34 392.15 56 357.95 78 598.83 100 240.41 
13 504.59 35 329.24 57 351.96 79 339.50 101 260.33 
14 455.02 36 357.40 58 221.79 80 194.9   
15 339.08 37 331.94 59 249.78 81 630.20   
16 316.87 38 519.49 60 428.12 82 573.49   
17 322.61 39 490.82 61 336.84 83 361.6   
18 424.83 40 361.54 62 375.22 84 171.96   
19 793.34 41 432.18 63 652.15 85 309.86   
20 683.69 42 613.35 64 695.22 86 330.97   
21 297.07 43 461.94 65 490.53 87 349.76   
22 346.05 44 525.11 66 639.95 88 369.01   
 




Figure A.1.1 Cell surface expression of EGFR’s. EGF-TMR (red) bound to EGFR on 





Figure A.1.2 Confocal 3D reconstruction of a single A431 cell in which the EGFR’s are 
bound to EGF-TMR. The zoomed in Image is captured with a 60x (1.35NA) objective 








Figure A.2.1 Cell seeding inside microchannel. Main inlet and outlet are closed while 
the cells are seeded through cell seeding inlet and collected through the seeding outlet. 
 
Figure A.2.2 Perfusion of media inside the microchannel during cell growth. A 1 mL 





Figure A.2.3 Growth of a monolayer of cells inside the microchannel. Figure shows 
fully confluent A431 cells grown inside the microchannel. 
 
 
Figure A.2.4 Bound ligand gradient (raw intensity signal) obtained by altering the 





Figure A.3.1 Confocal image of (a) fixed H9c2 cell (cardiomyocytes) expressing Beta 
Adrenergic receptor clusters. Receptors are labelled with NBD-Propranolol (non-
selectively stains intra and extracellular β1, β2 and β3 receptors). F-actin staining is also 
observed using Phalloidin-Alexa Fluor 546 confirming the presence of actin filaments 
in smooth muscle cells (b) Fixed H9c2 cell (cardiomyocytes) expressing Beta 




Figure A.3.2 Confocal 2D slices of live H9c2 cells labelled selectively with β1 pAb 
(green- binding to the n-terminal ectodomain of these receptors) while the nucleus is 






Figure A.4.1 Scanning electron photomicrograph of a 6 m thick PDMS layer coated 
on top of a glass coverslip. This thin coating of PDMS was essential to restrict cell 
attachment in areas which were not treated with fibronectin.   
 
Figure A.4.2 Phase contrast image of A431 cell island cultured inside the microfluidic 




Figure A.4.3 Fluorescent b/w (stitched) image of Fibronectin-Alexa 546 pattern on glass 
coverslip. 
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